<SEC-DOCUMENT>0001104659-25-015015.txt : 20250219
<SEC-HEADER>0001104659-25-015015.hdr.sgml : 20250219
<ACCEPTANCE-DATETIME>20250219092224
ACCESSION NUMBER:		0001104659-25-015015
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20250218
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250219
DATE AS OF CHANGE:		20250219

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AbbVie Inc.
		CENTRAL INDEX KEY:			0001551152
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				320375147
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35565
		FILM NUMBER:		25637670

	BUSINESS ADDRESS:	
		STREET 1:		1 NORTH WAUKEGAN ROAD
		CITY:			NORTH CHICAGO
		STATE:			IL
		ZIP:			60064
		BUSINESS PHONE:		(847) 932-7900

	MAIL ADDRESS:	
		STREET 1:		1 NORTH WAUKEGAN ROAD
		CITY:			NORTH CHICAGO
		STATE:			IL
		ZIP:			60064
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm255723d4_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:exch="http://xbrl.sec.gov/exch/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:abbv="http://abbvie.com/20250218">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_037_abbv_abbvie.com_20250218 -->
<!-- Field: Set; Name: xdx; ID: xdx_04A_20250218_20250218 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_055_edei%2D%2DEntityCentralIndexKey_0001551152 -->
<!-- Field: Set; Name: xdx; ID: xdx_072_SO_T%2D%2D\DeptFiles%2DiXBRL 8%2DK Covers Templates\+++%2DROOT%2DElement%2D+++\DocumentInformationLineItems.xdxs -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Arial, Helvetica, Sans-Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-02-18" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-02-18" id="Fact000004" name="dei:EntityCentralIndexKey">0001551152</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2025-02-182025-02-18_exch_XCHI_us-gaap_CommonStockMember" id="xdx2ixbrl0046" name="dei:Security12bTitle">Common Stock, $0.01 Par Value</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2025-02-182025-02-18_exch_XCHI_us-gaap_CommonStockMember" id="xdx2ixbrl0047" name="dei:TradingSymbol">ABBV</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="abbv-20250218.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-02-18">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-02-18</xbrli:startDate>
        <xbrli:endDate>2025-02-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-02-182025-02-18_us-gaap_CommonStockMember_exch_XNYS">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-02-18</xbrli:startDate>
        <xbrli:endDate>2025-02-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-02-182025-02-18_exch_XCHI_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XCHI</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-02-18</xbrli:startDate>
        <xbrli:endDate>2025-02-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-02-182025-02-18_custom_SeniorNotes0.750Percentdue2027Member_exch_XNYS">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">abbv:SeniorNotes0.750Percentdue2027Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-02-18</xbrli:startDate>
        <xbrli:endDate>2025-02-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-02-182025-02-18_custom_SeniorNotes2.125Percentdue2028Member_exch_XNYS">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">abbv:SeniorNotes2.125Percentdue2028Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-02-18</xbrli:startDate>
        <xbrli:endDate>2025-02-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-02-182025-02-18_custom_SeniorNotes2.625Percentdue2028Member_exch_XNYS">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">abbv:SeniorNotes2.625Percentdue2028Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-02-18</xbrli:startDate>
        <xbrli:endDate>2025-02-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-02-182025-02-18_custom_SeniorNotes2.125Percentdue2029Member_exch_XNYS">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">abbv:SeniorNotes2.125Percentdue2029Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-02-18</xbrli:startDate>
        <xbrli:endDate>2025-02-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-02-182025-02-18_custom_SeniorNotes1.250Percentdue2031Member_exch_XNYS">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">abbv:SeniorNotes1.250Percentdue2031Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-02-18</xbrli:startDate>
        <xbrli:endDate>2025-02-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0"></p>

<p style="margin: 0pt 0">&#160;</p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><p style="margin: 0pt 0">&#160;</p>

<p style="font: bold 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">UNITED
STATES</span></p>

<p style="font: bold 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">SECURITIES
AND EXCHANGE COMMISSION</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Washington,
D.C. 20549</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">FORM <span id="xdx_902_edei--DocumentType_c20250218__20250218_zHCYaLeq80xk"><ix:nonNumeric contextRef="AsOf2025-02-18" id="Fact000010" name="dei:DocumentType">8-K</ix:nonNumeric></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CURRENT
REPORT</span></p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to Section 13  OR 15(d) of the</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
Exchange Act of 1934</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Date of Report (Date of earliest event
reported):</b> <b><span id="xdx_901_edei--DocumentPeriodEndDate_c20250218__20250218_zhsLHx15l1B8"><ix:nonNumeric contextRef="AsOf2025-02-18" format="ixt:datemonthdayyearen" id="Fact000011" name="dei:DocumentPeriodEndDate">February 18, 2025</ix:nonNumeric>
</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 20pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_903_edei--EntityRegistrantName_c20250218__20250218_zOg7RzX17VM2" style="font-size: 18pt"><ix:nonNumeric contextRef="AsOf2025-02-18" id="Fact000012" name="dei:EntityRegistrantName">ABBVIE
INC.</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Exact name of registrant as specified in its charter)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="width: 32%; font-weight: bold; text-align: center"><span id="xdx_901_edei--EntityIncorporationStateCountryCode_c20250218__20250218_zB7prpiZE1Ul"><ix:nonNumeric contextRef="AsOf2025-02-18" format="ixt-sec:stateprovnameen" id="Fact000013" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></td>
    <td style="width: 2%; font-weight: bold; text-align: center">&#160;</td>
    <td style="width: 32%; font-weight: bold; text-align: center"><span id="xdx_90C_edei--EntityFileNumber_c20250218__20250218_zMaLsSUwkME6"><ix:nonNumeric contextRef="AsOf2025-02-18" id="Fact000014" name="dei:EntityFileNumber">001-35565</ix:nonNumeric></span></td>
    <td style="width: 2%; font-weight: bold; text-align: center">&#160;</td>
    <td style="width: 32%; font-weight: bold; text-align: center"><span id="xdx_909_edei--EntityTaxIdentificationNumber_c20250218__20250218_zqAGlrtJRQC9"><ix:nonNumeric contextRef="AsOf2025-02-18" id="Fact000015" name="dei:EntityTaxIdentificationNumber">32-0375147</ix:nonNumeric></span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center"><b>(State of Incorporation)</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td style="text-align: center"><b>(Commission File Number)</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td style="text-align: center"><b>(IRS Employer<br/> Identification Number)</b></td></tr>
</table>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 1pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_90D_edei--EntityAddressAddressLine1_c20250218__20250218_zvH8BS9mSgUi"><ix:nonNumeric contextRef="AsOf2025-02-18" id="Fact000016" name="dei:EntityAddressAddressLine1">1
North Waukegan Road</ix:nonNumeric></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_907_edei--EntityAddressCityOrTown_c20250218__20250218_zYGOlXuRaDQi"><ix:nonNumeric contextRef="AsOf2025-02-18" id="Fact000017" name="dei:EntityAddressCityOrTown">North
Chicago</ix:nonNumeric></span>, <span id="xdx_90A_edei--EntityAddressStateOrProvince_c20250218__20250218_zwnhRpxRFgbc"><ix:nonNumeric contextRef="AsOf2025-02-18" format="ixt-sec:stateprovnameen" id="Fact000018" name="dei:EntityAddressStateOrProvince">Illinois</ix:nonNumeric></span> <span id="xdx_905_edei--EntityAddressPostalZipCode_c20250218__20250218_zxFy4wfeh1x3"><ix:nonNumeric contextRef="AsOf2025-02-18" id="Fact000019" name="dei:EntityAddressPostalZipCode">60064-6400</ix:nonNumeric></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt"><b>(Address
of principal executive offices, including zip code)&#160;</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>(<span id="xdx_90F_edei--CityAreaCode_c20250218__20250218_zOJMxwfaz8R9"><ix:nonNumeric contextRef="AsOf2025-02-18" id="Fact000020" name="dei:CityAreaCode">847</ix:nonNumeric></span></b><b>)
<span id="xdx_903_edei--LocalPhoneNumber_c20250218__20250218_zxRyJgzkgzKg"><ix:nonNumeric contextRef="AsOf2025-02-18" id="Fact000021" name="dei:LocalPhoneNumber">932-7900</ix:nonNumeric></span></b>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(<b>Registrant&#8217;s telephone
number, including area code</b>)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; text-align: left">Check the appropriate box below if the Form 8-K filing
is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.below):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
    <td style="padding-bottom: 1pt; width: 0.25in"><span style="font-family: Wingdings"><span id="xdx_909_edei--WrittenCommunications_c20250218__20250218_zLZGd1ynKxel"><ix:nonNumeric contextRef="AsOf2025-02-18" format="ixt:booleanfalse" id="Fact000022" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></span></td>
    <td style="padding-bottom: 1pt; text-align: justify">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</td></tr>

<tr style="vertical-align: top">
    <td style="padding-bottom: 1pt; width: 0.25in"><span style="font-family: Wingdings"><span id="xdx_909_edei--SolicitingMaterial_c20250218__20250218_zsc4tLot87ha"><ix:nonNumeric contextRef="AsOf2025-02-18" format="ixt:booleanfalse" id="Fact000023" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></span></td>
    <td style="padding-bottom: 1pt; text-align: justify">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</td></tr>

<tr style="vertical-align: top">
    <td style="padding-bottom: 1pt; width: 0.25in"><span style="font-family: Wingdings"><span id="xdx_90C_edei--PreCommencementTenderOffer_c20250218__20250218_zXY2hQKWrbSg"><ix:nonNumeric contextRef="AsOf2025-02-18" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></span></td>
    <td style="padding-bottom: 1pt; text-align: justify">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</td></tr>

<tr style="vertical-align: top">
    <td style="padding-bottom: 1pt; width: 0.25in"><span style="font-family: Wingdings"><span id="xdx_90A_edei--PreCommencementIssuerTenderOffer_c20250218__20250218_zwiTIhcceD86"><ix:nonNumeric contextRef="AsOf2025-02-18" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></span></td>
    <td style="padding-bottom: 1pt; text-align: justify">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; text-align: left">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: left">Emerging growth company <span style="font-family: Wingdings"><span id="xdx_900_edei--EntityEmergingGrowthCompany_c20250218__20250218_zpJoDWBzzZJh"><ix:nonNumeric contextRef="AsOf2025-02-18" format="ixt:booleanfalse" id="Fact000026" name="dei:EntityEmergingGrowthCompany">&#168;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; text-align: left">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <span style="font-family: Wingdings">&#168;</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Securities
registered pursuant to Section 12(b) of the Act:</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; width: 32%; font-weight: bold; text-align: center; padding-left: 5.4pt; vertical-align: bottom"><span style="font-size: 9pt">Title
    of each class</span></td>
    <td style="width: 2%; font-weight: bold; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 32%; font-weight: bold; text-align: center; padding-left: 5.4pt; vertical-align: bottom"><span style="font-size: 9pt">Trading
    Symbol(s)</span></td>
    <td style="width: 2%; font-weight: bold; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 32%; font-weight: bold; text-align: center"><span style="font-size: 9pt">Name
    of each exchange on which <br/>
registered</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center; padding-left: 5.4pt"><span id="xdx_90F_edei--Security12bTitle_c20250218__20250218__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember__dei--EntityListingsExchangeAxis__exch--XNYS_zQ1Sdr3s6go6" style="font-size: 9pt"><ix:nonNumeric contextRef="From2025-02-182025-02-18_us-gaap_CommonStockMember_exch_XNYS" id="Fact000027" name="dei:Security12bTitle">Common
    Stock, $0.01 Par Value</ix:nonNumeric></span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center; padding-left: 5.4pt"><span id="xdx_904_edei--TradingSymbol_c20250218__20250218__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember__dei--EntityListingsExchangeAxis__exch--XNYS_zOoNHEE1Yiqh" style="font-size: 9pt"><ix:nonNumeric contextRef="From2025-02-182025-02-18_us-gaap_CommonStockMember_exch_XNYS" id="Fact000028" name="dei:TradingSymbol">ABBV</ix:nonNumeric></span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span id="xdx_90C_edei--SecurityExchangeName_c20250218__20250218__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember__dei--EntityListingsExchangeAxis__exch--XNYS_ztVLsFRm7dz4" style="font-size: 9pt"><ix:nonNumeric contextRef="From2025-02-182025-02-18_us-gaap_CommonStockMember_exch_XNYS" format="ixt-sec:exchnameen" id="Fact000029" name="dei:SecurityExchangeName">New
    York Stock Exchange</ix:nonNumeric></span> <span style="font-size: 9pt"><br/><span id="xdx_905_edei--SecurityExchangeName_c20250218__20250218__dei--EntityListingsExchangeAxis__exch--XCHI__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zaw8X8vm8ZRj"><ix:nonNumeric contextRef="From2025-02-182025-02-18_exch_XCHI_us-gaap_CommonStockMember" format="ixt-sec:exchnameen" id="Fact000030" name="dei:SecurityExchangeName">Chicago
    Stock Exchange</ix:nonNumeric></span></span></td></tr>

<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90C_edei--Security12bTitle_c20250218__20250218__us-gaap--StatementClassOfStockAxis__custom--SeniorNotes0.750Percentdue2027Member__dei--EntityListingsExchangeAxis__exch--XNYS_zguNBkvxENy3" style="font-size: 9pt"><ix:nonNumeric contextRef="From2025-02-182025-02-18_custom_SeniorNotes0.750Percentdue2027Member_exch_XNYS" id="Fact000031" name="dei:Security12bTitle">0.750%
    Senior Notes due 2027</ix:nonNumeric></span></td>
    <td><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90A_edei--TradingSymbol_c20250218__20250218__us-gaap--StatementClassOfStockAxis__custom--SeniorNotes0.750Percentdue2027Member__dei--EntityListingsExchangeAxis__exch--XNYS_zYoNpv2LNCjg" style="font-size: 9pt"><ix:nonNumeric contextRef="From2025-02-182025-02-18_custom_SeniorNotes0.750Percentdue2027Member_exch_XNYS" id="Fact000032" name="dei:TradingSymbol">ABBV27</ix:nonNumeric></span></td>
    <td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span id="xdx_904_edei--SecurityExchangeName_c20250218__20250218__us-gaap--StatementClassOfStockAxis__custom--SeniorNotes0.750Percentdue2027Member__dei--EntityListingsExchangeAxis__exch--XNYS_z4x3ByiyUTM7" style="font-size: 9pt"><ix:nonNumeric contextRef="From2025-02-182025-02-18_custom_SeniorNotes0.750Percentdue2027Member_exch_XNYS" format="ixt-sec:exchnameen" id="Fact000033" name="dei:SecurityExchangeName">New
    York Stock Exchange</ix:nonNumeric></span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_909_edei--Security12bTitle_c20250218__20250218__us-gaap--StatementClassOfStockAxis__custom--SeniorNotes2.125Percentdue2028Member__dei--EntityListingsExchangeAxis__exch--XNYS_z51FCh2KNo18" style="font-size: 9pt"><ix:nonNumeric contextRef="From2025-02-182025-02-18_custom_SeniorNotes2.125Percentdue2028Member_exch_XNYS" id="Fact000034" name="dei:Security12bTitle">2.125%
    Senior Notes Due 2028</ix:nonNumeric></span></td>
    <td><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_904_edei--TradingSymbol_c20250218__20250218__us-gaap--StatementClassOfStockAxis__custom--SeniorNotes2.125Percentdue2028Member__dei--EntityListingsExchangeAxis__exch--XNYS_zIj36ylmU7ff" style="font-size: 9pt"><ix:nonNumeric contextRef="From2025-02-182025-02-18_custom_SeniorNotes2.125Percentdue2028Member_exch_XNYS" id="Fact000035" name="dei:TradingSymbol">ABBV28</ix:nonNumeric></span></td>
    <td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span id="xdx_905_edei--SecurityExchangeName_c20250218__20250218__us-gaap--StatementClassOfStockAxis__custom--SeniorNotes2.125Percentdue2028Member__dei--EntityListingsExchangeAxis__exch--XNYS_zQoaQrqBFGS2" style="font-size: 9pt"><ix:nonNumeric contextRef="From2025-02-182025-02-18_custom_SeniorNotes2.125Percentdue2028Member_exch_XNYS" format="ixt-sec:exchnameen" id="Fact000036" name="dei:SecurityExchangeName">New
    York Stock Exchange</ix:nonNumeric></span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90C_edei--Security12bTitle_c20250218__20250218__us-gaap--StatementClassOfStockAxis__custom--SeniorNotes2.625Percentdue2028Member__dei--EntityListingsExchangeAxis__exch--XNYS_z0apdGhPJhhl" style="font-size: 9pt"><ix:nonNumeric contextRef="From2025-02-182025-02-18_custom_SeniorNotes2.625Percentdue2028Member_exch_XNYS" id="Fact000037" name="dei:Security12bTitle">2.625%
    Senior Notes Due 2028</ix:nonNumeric></span></td>
    <td><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_906_edei--TradingSymbol_c20250218__20250218__us-gaap--StatementClassOfStockAxis__custom--SeniorNotes2.625Percentdue2028Member__dei--EntityListingsExchangeAxis__exch--XNYS_zFw3JZcICeBf" style="font-size: 9pt"><ix:nonNumeric contextRef="From2025-02-182025-02-18_custom_SeniorNotes2.625Percentdue2028Member_exch_XNYS" id="Fact000038" name="dei:TradingSymbol">ABBV28B</ix:nonNumeric></span></td>
    <td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span id="xdx_909_edei--SecurityExchangeName_c20250218__20250218__us-gaap--StatementClassOfStockAxis__custom--SeniorNotes2.625Percentdue2028Member__dei--EntityListingsExchangeAxis__exch--XNYS_zrR52NOQ4xel" style="font-size: 9pt"><ix:nonNumeric contextRef="From2025-02-182025-02-18_custom_SeniorNotes2.625Percentdue2028Member_exch_XNYS" format="ixt-sec:exchnameen" id="Fact000039" name="dei:SecurityExchangeName">New
    York Stock Exchange</ix:nonNumeric></span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_905_edei--Security12bTitle_c20250218__20250218__us-gaap--StatementClassOfStockAxis__custom--SeniorNotes2.125Percentdue2029Member__dei--EntityListingsExchangeAxis__exch--XNYS_zFnipjo2jXtl" style="font-size: 9pt"><ix:nonNumeric contextRef="From2025-02-182025-02-18_custom_SeniorNotes2.125Percentdue2029Member_exch_XNYS" id="Fact000040" name="dei:Security12bTitle">2.125%
    Senior Notes due 2029</ix:nonNumeric></span></td>
    <td><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90A_edei--TradingSymbol_c20250218__20250218__us-gaap--StatementClassOfStockAxis__custom--SeniorNotes2.125Percentdue2029Member__dei--EntityListingsExchangeAxis__exch--XNYS_zjcNDSn3cohi" style="font-size: 9pt"><ix:nonNumeric contextRef="From2025-02-182025-02-18_custom_SeniorNotes2.125Percentdue2029Member_exch_XNYS" id="Fact000041" name="dei:TradingSymbol">ABBV29</ix:nonNumeric></span></td>
    <td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span id="xdx_908_edei--SecurityExchangeName_c20250218__20250218__us-gaap--StatementClassOfStockAxis__custom--SeniorNotes2.125Percentdue2029Member__dei--EntityListingsExchangeAxis__exch--XNYS_z6ff7pEE4Npe" style="font-size: 9pt"><ix:nonNumeric contextRef="From2025-02-182025-02-18_custom_SeniorNotes2.125Percentdue2029Member_exch_XNYS" format="ixt-sec:exchnameen" id="Fact000042" name="dei:SecurityExchangeName">New
    York Stock Exchange</ix:nonNumeric></span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90B_edei--Security12bTitle_c20250218__20250218__us-gaap--StatementClassOfStockAxis__custom--SeniorNotes1.250Percentdue2031Member__dei--EntityListingsExchangeAxis__exch--XNYS_zZgIIkPBxc5i" style="font-size: 9pt"><ix:nonNumeric contextRef="From2025-02-182025-02-18_custom_SeniorNotes1.250Percentdue2031Member_exch_XNYS" id="Fact000043" name="dei:Security12bTitle">1.250%
    Senior Notes due 2031</ix:nonNumeric></span></td>
    <td><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90D_edei--TradingSymbol_c20250218__20250218__us-gaap--StatementClassOfStockAxis__custom--SeniorNotes1.250Percentdue2031Member__dei--EntityListingsExchangeAxis__exch--XNYS_zqZkxasawFG3" style="font-size: 9pt"><ix:nonNumeric contextRef="From2025-02-182025-02-18_custom_SeniorNotes1.250Percentdue2031Member_exch_XNYS" id="Fact000044" name="dei:TradingSymbol">ABBV31</ix:nonNumeric></span></td>
    <td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span id="xdx_906_edei--SecurityExchangeName_c20250218__20250218__us-gaap--StatementClassOfStockAxis__custom--SeniorNotes1.250Percentdue2031Member__dei--EntityListingsExchangeAxis__exch--XNYS_zsr8pM8o36b" style="font-size: 9pt"><ix:nonNumeric contextRef="From2025-02-182025-02-18_custom_SeniorNotes1.250Percentdue2031Member_exch_XNYS" format="ixt-sec:exchnameen" id="Fact000045" name="dei:SecurityExchangeName">New
    York Stock Exchange</ix:nonNumeric></span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table border="0" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
<td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90A_edei--Security12bTitle_dxL_c20250218__20250218__dei--EntityListingsExchangeAxis__exch--XCHI__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z6gxbr8S7Sk1" style="display: none; visibility: hidden"><span style="-sec-ix-hidden: xdx2ixbrl0046">Common Stock, $0.01 Par Value</span></span></span></td>
<td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_909_edei--TradingSymbol_dxL_c20250218__20250218__dei--EntityListingsExchangeAxis__exch--XCHI__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zVzdzXAHCf0i" style="display: none; visibility: hidden"><span style="-sec-ix-hidden: xdx2ixbrl0047">ABBV</span></span></span></td>
</tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 8.01. Other Events.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On February 18, 2025, AbbVie Inc. (&#8220;<span style="text-decoration: underline">AbbVie</span>&#8221;)
entered into an underwriting agreement (the &#8220;<span style="text-decoration: underline">Underwriting Agreement</span>&#8221;) with BofA Securities, Inc., J.P. Morgan Securities
LLC, Morgan Stanley &amp; Co. LLC, Barclays Capital Inc. and Mizuho Securities USA LLC, acting for themselves and as representatives of
the several underwriters named in Schedule II therein (collectively, the &#8220;<span style="text-decoration: underline">Underwriters</span>&#8221;), pursuant to which AbbVie
agreed to issue and sell to the Underwriters $1,250,000,000 in aggregate principal amount of its 4.650% senior notes due 2028 (the &#8220;<span style="text-decoration: underline">2028
Notes</span>&#8221;), $1,000,000,000 in aggregate principal amount of its 4.875% senior notes due 2030 (the &#8220;<span style="text-decoration: underline">2030 Notes</span>&#8221;),
$1,000,000,000 in aggregate principal amount of its 5.2000% senior notes due 2035 (the &#8220;<span style="text-decoration: underline">2035 Notes</span>&#8221;) and $750,000,000
in aggregate principal amount of its 5.600% senior notes due 2055 (the &#8220;<span style="text-decoration: underline">2055 Notes</span>&#8221; and, together with the 2028 Notes,
the 2030 Notes and the 2035 Notes, the &#8220;<span style="text-decoration: underline">Notes</span>&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The price to the public was 99.867% of the principal
amount for the 2028 Notes, 99.908% of the principal amount for the 2030 Notes, 99.857% of the principal amount for the 2035 Notes and
99.750% of the principal amount for the 2055 Notes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The offering of each series of Notes has been registered
under the Securities Act of 1933, as amended (the &#8220;<span style="text-decoration: underline">Act</span>&#8221;), pursuant to AbbVie&#8217;s registration statement on Form
S-3ASR (File No.&#160;333-284980) (the &#8220;<span style="text-decoration: underline">Registration Statement</span>&#8221;) dated as of February 14, 2025. The terms of the Notes
are further described in AbbVie&#8217;s preliminary prospectus supplement dated February 18, 2025, as filed with the Securities and Exchange
Commission (the &#8220;<span style="text-decoration: underline">SEC</span>&#8221;) on February 18, 2025 and final prospectus supplement dated February 18, 2025, to be filed with
the SEC on or prior to February 20, 2025 (the &#8220;<span style="text-decoration: underline">Prospectus Supplement</span>&#8221;). The closing of the sale of the Notes is expected
to occur on February 26, 2025, subject to customary closing conditions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The net proceeds from the sale of the Notes, after
deducting the underwriting discounts and&#8239;before estimated offering expenses, are expected to be approximately $3.98 billion. AbbVie intends to
use these net proceeds, together with cash on hand, (a) to repurchase, redeem, satisfy and discharge, defease, make a tender offer for,
or otherwise repay at maturity (i) all of its 3.600% senior notes due 2025, which have a stated maturity date of May 14, 2025, in an aggregate
outstanding principal amount of $3.750 billion, and/or (ii) all of its 3.800% senior notes due 2025, which have a stated maturity date
of March 15, 2025, in an aggregate outstanding principal amount of $2.890 billion, and/or (iii) all of the 3.800% senior notes due 2025
of Allergan Funding SCS (formerly known as Actavis Funding SCS), which have a stated maturity date of March 15, 2025, in an aggregate
principal amount of $130.225 million, and, in each case, to pay any premium and accrued and unpaid interest in respect thereof, and/or
(b) for general corporate purposes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Underwriting Agreement includes customary representations,
warranties and covenants by AbbVie. It also provides for customary indemnification by each of AbbVie and the respective Underwriters against
certain liabilities arising out of or in connection with sale of the Notes and for customary contribution provisions in respect of those
liabilities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As more fully described under the caption &#8220;Underwriting&#8221;
in the Prospectus Supplement, some of the underwriters in respect of the Underwriting Agreement and/or their affiliates have in the past
performed, and may in the future from time to time perform, investment banking, financial advisory, lending and/or commercial banking
services, or other services for AbbVie and its subsidiaries, for which they have received, and may in the future receive, customary compensation
and expense reimbursement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Please refer to the Prospectus Supplement for additional
information regarding the offering of the Notes and the terms and conditions of the Notes. The foregoing summary of the Notes does not
purport to be complete and is qualified in its entirety by reference to the full text of the Underwriting Agreement, which is attached
as Exhibit 1.1 hereto and is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 9.01. Financial Statements and Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(d) <span style="text-decoration: underline">Exhibits</span>. The following exhibit is provided as part of this
Form 8-K:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="padding: 0.25pt; width: 4%"><a href="tm255723d4_ex1-1.htm"><span style="font-size: 10pt">1.1</span></a></td>
    <td style="padding: 0.25pt; width: 96%"><a href="tm255723d4_ex1-1.htm"><span style="font-size: 10pt">Underwriting Agreement, dated February 18, 2025, by and among AbbVie Inc., BofA Securities, Inc., J.P. Morgan Securities LLC, Morgan Stanley &amp; Co. LLC, Barclays Capital Inc. and Mizuho Securities USA LLC (acting for themselves and as representatives of the several underwriters named therein).</span></a></td></tr>
  <tr style="vertical-align: top">
    <td style="padding: 0.25pt">&#160;</td>
    <td style="padding: 0.25pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding: 0.25pt"><span style="font-size: 10pt">104</span></td>
    <td style="padding: 0.25pt">Cover Page Interactive Data File (embedded within the Inline XBRL document).</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Forward Looking Statements</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Some statements in this Current Report on Form
8-K and the documents incorporated by reference into this Current Report on Form 8-K are, or may be considered, forward-looking statements
for purposes of the Private Securities Litigation Reform Act of 1995 (&#8220;<span style="text-decoration: underline">PSLRA</span>&#8221;). The words &#8220;believe,&#8221; &#8220;expect,&#8221;
&#8220;anticipate,&#8221; &#8220;project&#8221; and similar expressions and uses of future or conditional verbs, generally identify &#8220;forward
looking statements,&#8221; which speak only as of the date the statements were made. The matters discussed in these forward-looking statements
are subject to risks, uncertainties and other factors that could cause actual results to differ materially from those expressed or implied
in the forward-looking statements. Where, in any forward looking statement, an expectation or belief as to future results or events is
expressed or implied, such expectation or belief is based on the current plans and expectations of AbbVie management and expressed in
good faith and believed to have a reasonable basis, but there can be no assurance that the expectation or belief will result or be achieved
or accomplished. Factors that could cause actual results or events to differ materially from those anticipated include, but are not limited
to, the matters described under Item 1A, &#8220;Risk Factors,&#8221; and Item 7, &#8220;Management&#8217;s Discussion and Analysis of
Financial Condition and Results of Operations,&#8221; in AbbVie&#8217;s Annual Report on Form 10-K for the year ended December 31, 2024,
which has been filed with the SEC. AbbVie notes these factors for investors as permitted by the PSLRA. AbbVie does not undertake, and
specifically declines, any obligation to update the forward-looking statements included in this Current Report on Form 8-K to reflect
events or circumstances after the date hereof, unless AbbVie is required by applicable securities law to do so.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
<td style="padding-right: 0.25pt; padding-left: 0.25pt"><span style="font-size: 10pt">&#160;</span></td>
<td colspan="2" style="padding-right: 0.25pt; padding-left: 0.25pt"><span style="font-size: 10pt"><b>ABBVIE INC.</b></span></td></tr>
<tr style="vertical-align: top">
<td style="width: 50%; padding-right: 0.25pt; padding-left: 0.25pt"><span style="font-size: 10pt">&#160;</span></td>
<td style="width: 5%; padding-right: 0.25pt; padding-left: 0.25pt"><span style="font-size: 10pt">&#160;</span></td>
<td style="width: 45%; padding-right: 0.25pt; padding-left: 0.25pt"><span style="font-size: 10pt">&#160;</span></td>
</tr>
<tr style="vertical-align: top">
<td style="padding-right: 0.25pt; padding-left: 0.25pt; font-size: 10pt"><span style="font-size: 10pt">Date: February 19, 2025</span></td>
<td style="padding-right: 0.25pt; padding-left: 0.25pt; font-size: 10pt"><span style="font-size: 10pt">By:</span></td>
<td style="border-bottom: black 1pt solid; padding-right: 0.25pt; padding-left: 0.25pt; font-size: 10pt"><span style="font-size: 10pt">/s/ Scott
T. Reents</span></td>
</tr>
<tr style="vertical-align: top">
<td style="padding-right: 0.25pt; padding-left: 0.25pt"><span style="font-size: 10pt">&#160;</span></td>
<td style="padding-right: 0.25pt; padding-left: 0.25pt"><span style="font-size: 10pt">&#160;</span></td>
<td style="padding-right: 0.25pt; padding-left: 0.25pt; font-size: 10pt"><span style="font-size: 10pt">Scott T. Reents</span></td>
</tr>
<tr style="vertical-align: top">
<td style="padding-right: 0.25pt; padding-left: 0.25pt"><span style="font-size: 10pt">&#160;</span></td>
<td style="padding-right: 0.25pt; padding-left: 0.25pt"><span style="font-size: 10pt">&#160;</span></td>
<td style="white-space: nowrap; padding-right: 0.25pt; padding-left: 0.25pt; font-size: 10pt"><span style="font-size: 10pt">Executive Vice President, Chief Financial
Officer</span></td>
</tr>
</table>










<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjUEKwjAQRU/QOwxZi02D3XRpqSJWkSLiNthRgm2mTKK2R/KWxhZxGBiG/9//QszEmlamQYbzsirhiG3XaI9Q4RUZ7QWDI99sMwi3wptxnrX14/sDcwoMBiadq1QHYbQ+jcM6A6liuYhVCjLJUgWHnYi+ek72amq03ugGtK3hwNSxQa95mBKOuidL7TBWnZCdIZtBMpeT/AYlEwV7euoX8d1BWeYimo0TiTXTowuuovdovyQUDbahzk30f6MPBT5Kig== -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>tm255723d4_ex1-1.htm
<DESCRIPTION>EXHIBIT 1.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 1.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">ABBVIE INC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">$1,250,000,000 4.650% Senior
Notes due 2028</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">$1,000,000,000 4.875% Senior
Notes due 2030</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">$1,000,000,000 5.200% Senior
Notes due 2035</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">$750,000,000 5.600% Senior Notes
due 2055</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>UNDERWRITING AGREEMENT</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in">February 18, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">BofA Securities,&nbsp;Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">One Bryant Park</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">New York, New York 10036</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">J.P. Morgan Securities LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">383 Madison Avenue</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">New York, New York 10179</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Morgan Stanley&nbsp;&amp; Co. LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">1585 Broadway</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">New York, New York 10036</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Barclays Capital Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">745 Seventh Ave</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">New York, New York 10019</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Mizuho Securities USA LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">1271 Avenue of the Americas</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">New York, New York 10020</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As representatives of the several Underwriters&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">named in Schedule II hereto</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">AbbVie Inc., a Delaware corporation (the &ldquo;<B>Company</B>&rdquo;),
proposes to issue and sell to BofA Securities, Inc., J.P. Morgan Securities LLC, Morgan Stanley &amp; Co. LLC, Barclays Capital Inc. and
Mizuho Securities USA LLC (together, the &ldquo;<B>Representatives</B>&rdquo;) and the other several underwriters named in Schedule II
hereto (together with the Representatives, the &ldquo;<B>Underwriters</B>&rdquo;) pursuant to this Underwriting Agreement (this &ldquo;<B>Agreement</B>&rdquo;)
the principal amount of its debt securities identified in Schedule I hereto (the &ldquo;<B>Securities</B>&rdquo;), to be issued pursuant
to the indenture dated as of November 8, 2012 (the &ldquo;<B>Base Indenture</B>&rdquo;) between the Company and U.S. Bank Trust Company,
National Association (successor to U.S. Bank National Association), as Trustee (the &ldquo;<B>Trustee</B>&rdquo;), as supplemented by
Supplemental Indenture No. 11 to be dated as of February 26, 2025 between the Company and the Trustee (the &ldquo;<B>Supplemental Indenture</B>&rdquo;,
and the Base Indenture as supplemented by the Supplemental Indenture, the &ldquo;<B>Indenture</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Company has filed with the Securities and Exchange
Commission (the &ldquo;<B>Commission</B>&rdquo;) a registration statement, including a prospectus, (the file number of which is set forth
in Schedule&nbsp;I hereto) on Form S-3, relating to securities (the &ldquo;<B>Shelf Securities</B>&rdquo;), including the Securities,
to be issued from time to time by the Company. The registration statement as amended to the date of this Agreement, including the information
(if any) deemed to be part of the registration statement at the time of effectiveness pursuant to Rule&nbsp;430A or Rule 430B under the
Securities Act of 1933, as amended (the &ldquo;<B>Securities Act</B>&rdquo;), including all exhibits thereto (but excluding Form T-1),
is hereinafter referred to as the &ldquo;<B>Registration Statement</B>,&rdquo; and the related prospectus covering the Shelf Securities
dated February 14, 2025 is hereinafter referred to as the &ldquo;<B>Basic Prospectus</B>.&rdquo; The Basic Prospectus, as supplemented
by the prospectus supplement specifically relating to the Securities in the form first used to confirm sales of the Securities (or in
the form first made available to the Underwriters by the Company to meet requests of purchasers pursuant to Rule 173 under the Securities
Act) is hereinafter referred to as the &ldquo;<B>Prospectus</B>,&rdquo; and the term &ldquo;<B>preliminary prospectus</B>&rdquo; means
any preliminary form of the Prospectus. For purposes of this Agreement, &ldquo;<B>free writing prospectus</B>&rdquo; has the meaning set
forth in Rule 405 under the Securities Act and relating to the offering of the Securities, &ldquo;<B>Time of Sale Prospectus</B>&rdquo;
means the documents and pricing information set forth opposite the caption &ldquo;Time of Sale Prospectus&rdquo; in Schedule I hereto,
and &ldquo;<B>broadly available road show</B>&rdquo; means a &ldquo;bona fide electronic road show&rdquo; as defined in Rule 433(h)(5)
under the Securities Act that has been made available without restriction to any person. As used herein, the terms &ldquo;<B>Registration
Statement</B>,&rdquo; &ldquo;<B>Basic Prospectus</B>,&rdquo; &ldquo;<B>preliminary prospectus</B>,&rdquo; &ldquo;<B>Time of Sale Prospectus</B>&rdquo;
and &ldquo;<B>Prospectus</B>&rdquo; shall include the documents, if any, incorporated by reference therein as of the date hereof. The
terms &ldquo;<B>supplement</B>,&rdquo; &ldquo;<B>amendment</B>,&rdquo; and &ldquo;<B>amend</B>&rdquo; as used herein with respect to the
Registration Statement, the Basic Prospectus, the Time of Sale Prospectus, any preliminary prospectus or the Prospectus shall include
all documents subsequently filed by the Company with the Commission pursuant to the Securities Exchange Act of 1934, as amended (the &ldquo;<B>Exchange
Act</B>&rdquo;), that are deemed to be incorporated by reference therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Company understands that the Underwriters propose,
subject to the provisions hereof and the selling restrictions disclosed in the Prospectus, to make a public offering of the Securities
as soon as the Representatives deem advisable after this Agreement has been executed and delivered.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><I>Representations
and Warranties of the Company</I>. The Company represents and warrants to, and agrees with, each of the Representatives that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>No
Stop Order; Status as a Well-Known Seasoned Issuer</U>. The Registration Statement has become effective; no stop order suspending the
effectiveness of the Registration Statement is in effect, and no proceedings for such purpose or pursuant to Section&nbsp;8A under the
Securities Act are pending before or, to the knowledge of the Company, threatened by the Commission. If the Registration Statement is
an automatic shelf registration statement as defined in Rule&nbsp;405 under the Securities Act, the Company is a well-known seasoned issuer
(as defined in Rule&nbsp;405 under the Securities Act) eligible to use the Registration Statement as an automatic shelf registration statement
and the Company has not received notice that the Commission objects to the use of the Registration Statement as an automatic shelf registration
statement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT>&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Registration
Statement, Prospectus and Disclosure at Time of Sale</U>. (i)&nbsp;Each document, if any, filed or to be filed pursuant to the Exchange
Act and incorporated by reference in the Time of Sale Prospectus or the Prospectus complied or will comply when so filed in all material
respects with the Exchange Act and the applicable rules&nbsp;and regulations of the Commission thereunder, (ii)&nbsp;each part of the
Registration Statement, when such part became effective, did not contain, and each such part, as amended or supplemented, if applicable,
will not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in
order to make the statements therein not misleading, (iii)&nbsp;the Registration Statement as of the date hereof does not contain any
untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements
therein not misleading, (iv)&nbsp;the Registration Statement and the Prospectus comply, and as amended or supplemented, if applicable,
will comply in all material respects with the Securities Act and the applicable rules&nbsp;and regulations of the Commission thereunder,
(v)&nbsp;each broadly available road show, if any, when considered together with the Time of Sale Prospectus, does not contain any untrue
statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances
under which they were made, not misleading, (vi)&nbsp;the Time of Sale Prospectus does not, and at the time of each sale of the Securities
in connection with the offering when the Prospectus is not yet available to prospective purchasers and at the Closing Date (as defined
in Section&nbsp;4), the Time of Sale Prospectus, as then amended or supplemented by the Company, if applicable, will not, contain any
untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of
the circumstances under which they were made, not misleading, and (vii)&nbsp;the Prospectus does not contain and, as amended or supplemented,
if applicable, will not contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the
statements therein, in the light of the circumstances under which they were made, not misleading, except that the representations and
warranties set forth in this paragraph do not apply to (A)&nbsp;statements or omissions in the Registration Statement, the Time of Sale
Prospectus or the Prospectus based upon the Underwriters&rsquo; Information (as defined in Section&nbsp;8(b)&nbsp;below) relating to any
Underwriter furnished to the Company in writing by such Underwriter through the Representatives expressly for use therein or (B)&nbsp;that
part of the Registration Statement that constitutes the Statement of Eligibility (Form&nbsp;T-1) under the Trust Indenture Act of 1939,
as amended (the &ldquo;<B>Trust Indenture Act</B>&rdquo;), of the Trustee;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Ineligible
Issuer</U>. The Company is not an &ldquo;ineligible issuer&rdquo; in connection with the offering pursuant to Rules&nbsp;164, 405 and
433 under the Securities Act. Any free writing prospectus that the Company is required to file pursuant to Rule&nbsp;433(d)&nbsp;under
the Securities Act in connection with the offering of the Securities has been, or will be, filed with the Commission in accordance with
the requirements of the Securities Act and the applicable rules&nbsp;and regulations of the Commission thereunder. Each free writing prospectus
that the Company has filed, or is required to file, pursuant to Rule&nbsp;433(d)&nbsp;under the Securities Act or that was prepared by
or on behalf of or used or referred to by the Company as of its date and at all times through the completion of the offering of the Securities
complies or will comply in all material respects with the requirements of the Securities Act and the applicable rules&nbsp;and regulations
of the Commission thereunder; Except for the free writing prospectuses, if any, identified in Schedule I hereto, forming part of the Time
of Sale Prospectus, and electronic road shows, if any, each furnished to you before first use, the Company has not prepared, used or referred
to, and will not, without your prior consent, prepare, use or refer to, any free writing prospectus in connection with the offering of
the Securities;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT>&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.75in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Incorporated
Documents</U>. The documents incorporated or deemed to be incorporated by reference in the Registration Statement and the Prospectus,
at the time they were or hereafter are filed with the Commission, complied and will comply in all material respects with the requirements
of the Securities Act and the Exchange Act and the rules and regulations of the Commission thereunder, as applicable, and, when read
together with the other information in the Prospectus, (a) at the time the Registration Statement became effective, (b) at the Applicable
Time and (c) at the Closing Date (as defined below) did not contain an untrue statement of a material fact or omit to state a material
fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they
were made, not misleading. As used in this Agreement, &ldquo;<B>Applicable Time</B>&rdquo; means 3:45 P.M. (New York City time) on February
18, 2025;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>No
Material Adverse Change in Company Business</U>. Neither the Company nor any of its subsidiaries has sustained since the date of the latest
audited financial statements included or incorporated by reference in the Registration Statement, Time of Sale Prospectus and the Prospectus
any loss or interference with its business from fire, explosion, flood or other calamity, whether or not covered by insurance, or from
any labor dispute or court or governmental action, order or decree, in each case which is material to the Company and its subsidiaries
taken as a whole, otherwise than as set forth or contemplated in the Registration Statement, the Time of Sale Prospectus or the Prospectus;
and, since the respective dates as of which information is given in the Registration Statement, the Time of Sale Prospectus and the Prospectus,
there has not been any material change in the consolidated capital stock or any material increase in the consolidated long-term debt of
the Company and its subsidiaries, taken as a whole, or any material adverse change, or any development involving a prospective material
adverse change, in or affecting the business, financial position, shareholders&rsquo; equity or results of operations of the Company and
its subsidiaries, taken as a whole, otherwise than as set forth or contemplated in the Time of Sale Prospectus;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Good
Standing of the Company</U>. The Company has been duly incorporated and is validly existing as a corporation in good standing under the
laws of the State of Delaware, has the corporate power and authority to own or lease its properties and conduct its business as described
in each of the Registration Statement, the Time of Sale Prospectus and the Prospectus, and is duly qualified to transact business and
is in good standing in each jurisdiction in which the conduct of its business or the ownership or leasing of its property requires such
qualification, except where failure to be so qualified or in good standing would not, in the aggregate, have a material adverse effect
upon the Company and its subsidiaries, taken as a whole;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(g)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Good
Standing of Subsidiaries</U>. Each of the &ldquo;significant subsidiaries&rdquo; of the Company (as such term is defined in Rule&nbsp;1-02(w)&nbsp;of
Regulation S-X promulgated under the Securities Act) has been duly incorporated, organized or formed, is validly existing as a corporation
or business entity in good standing under the laws of the jurisdiction of its incorporation, organization or formation, is duly qualified
to transact business and is in good standing in each jurisdiction in which the conduct of its business or the ownership or leasing of
its property requires such qualification, except where failure to be so qualified or in good standing would not, in the aggregate, have
a material adverse effect upon the Company and its subsidiaries, taken as a whole;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></FONT>&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(h)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Authorization
of this Agreement</U>. This Agreement has been duly authorized, executed and delivered by the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Authorization
of the Securities</U>. The Securities have been duly authorized and, when executed and authenticated and registered in the name of the
holders thereof in the register of holders maintained for such purposes, in each case, in accordance with the provisions of the Indenture,
and delivered to and paid for by the Underwriters, in accordance with the terms of this Agreement, will be valid and binding obligations
of the Company, enforceable in accordance with their terms, subject to applicable bankruptcy, insolvency, fraudulent transfer, reorganization,
moratorium and similar laws relating to or affecting creditors&rsquo; rights generally and general principles of equity (collectively,
the &ldquo;<B>Enforceability Exceptions</B>&rdquo;), and will be entitled to the benefits of the Indenture, subject to the Enforceability
Exceptions and except as rights to indemnification and contribution may be limited under applicable law;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(j)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Authorization
of the Indenture</U>. The Indenture has been duly authorized and, assuming due execution and delivery by the Trustee, when executed and
delivered by the Company, will be a valid and binding agreement of the Company, enforceable in accordance with its terms, subject to the
Enforceability Exceptions. The Indenture and the Securities will conform to the descriptions thereof contained in the Time of Sale Prospectus
as amended or supplemented with respect to such Securities;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(k)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Absence
of Defaults and Conflicts</U>. The issue and sale of the Securities and the compliance by the Company with all of the provisions of the
Securities, the Indenture and this Agreement, and the consummation of the transactions herein and therein contemplated, will not (i)&nbsp;conflict
with or result in a breach or violation of any of the terms or provisions of, or constitute a default under, or result in the creation
or imposition of any lien, charge or encumbrance upon any of the property or assets of the Company or any of its subsidiaries pursuant
to the terms of, any indenture, mortgage, deed of trust, loan agreement or other agreement or instrument to which the Company or any of
its subsidiaries is a party, or by which the Company or any of its subsidiaries is bound or to which any of the property or assets of
the Company or any of its subsidiaries is subject, (ii)&nbsp;result in any violation of the provisions of the articles of incorporation
or by-laws, each as amended, of the Company or (iii)&nbsp;result in a violation of any applicable law, statute or any order, rule&nbsp;or
regulation of any court or governmental agency or body having jurisdiction over the Company or any of its subsidiaries, or any of their
respective properties, in any such case described in clause (i)&nbsp;or (iii)&nbsp;the effects of which would, individually or in the
aggregate, be materially adverse to the Company and its subsidiaries, taken as a whole;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(l)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Absence
of Further Requirements</U>. No consent, approval, authorization, order, registration or qualification of or with any such court or governmental
agency or body is required for the issue and sale of the Securities or the consummation by the Company of the transactions contemplated
by this Agreement, the Securities or the Indenture except such as have already been obtained or may be required by the securities or Blue
Sky laws of the various states in connection with the offer and sale of the Securities and except as would not, individually or in the
aggregate, be materially adverse to the Company&rsquo;s ability to consummate the transactions contemplated by this Agreement, the Securities
or the Indenture or perform its obligations thereunder, as applicable;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></FONT>&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(m)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Absence
of Proceedings</U>. Other than as set forth in the Time of Sale Prospectus, there are no legal or governmental proceedings pending to
which the Company or any of its subsidiaries is a party or of which any property of the Company or any of its subsidiaries is the subject
(including, without limitation, any proceedings before the United States Food and Drug Administration or comparable Federal, state, local
or foreign governmental bodies) that, individually or in the aggregate, would reasonably be expected to have a material adverse effect
on the business, financial position, shareholders&rsquo; equity or results of operations of the Company and its subsidiaries, taken as
a whole; and, to the Company&rsquo;s knowledge, no such proceedings are threatened or contemplated by governmental authorities or threatened
by others;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(n)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>eXtensible
Business Reporting Language</U>. The interactive data in eXtensible Business Reporting Language included or incorporated by reference
in the Registration Statement fairly presents the information called for in all material respects and has been prepared in accordance
with the Commission&rsquo;s rules&nbsp;and guidelines applicable thereto;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(o)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Company
Financial Statements</U>. Except as noted therein, (i)&nbsp;the consolidated financial statements of the Company, and the related notes
thereto, contained in the Registration Statement, the Time of Sale Prospectus and the Prospectus present fairly in all material respects
the consolidated financial position of the Company and its consolidated subsidiaries as of the dates indicated and the results of their
operations and changes in their combined cash flows for the periods specified; (ii)&nbsp;such financial statements have been prepared
in conformity with accounting principles generally accepted in the United States applied on a consistent basis; and (iii)&nbsp;the selected
financial data of the Company and its subsidiaries contained in the Time of Sale Prospectus present fairly the information shown therein
and have been compiled on a basis consistent with that of the financial statements of the Company contained in the Time of Sale Prospectus.
The statistical, industry-related and market-related data included in each of the Registration Statement, the Time of Sale Prospectus
and the Prospectus are based on or derived from sources which the Company reasonably and in good faith believes are reliable and accurate
and such data is consistent with the sources from which they are derived, in each case in all material respects;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(p)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Compliance
with the Sarbanes-Oxley Act</U>. There is and has been no failure on the part of the Company or any of the Company&rsquo;s directors or
officers, in their capacities as such, to comply in all material respects with any provision of the Sarbanes-Oxley Act of 2002 and the
rules&nbsp;and regulations promulgated in connection therewith (the &ldquo;<B>Sarbanes-Oxley Act</B>&rdquo;), including Section&nbsp;402
related to loans and Sections 302 and 906 related to certifications;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(q)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Accounting
Controls</U>. The Company and its subsidiaries (i)&nbsp;make and keep accurate books and records in all material respects and (ii)&nbsp;maintain
internal accounting controls which provide reasonable assurance that (A)&nbsp;transactions are executed in accordance with management&rsquo;s
authorization, (B)&nbsp;transactions are recorded as necessary to permit preparation of their financial statements and to maintain accountability
for their assets, (C)&nbsp;access to their assets is permitted only in accordance with management&rsquo;s authorization and (D)&nbsp;the
reported accountability for their assets is compared with existing assets at reasonable intervals and appropriate action is taken with
respect to any difference;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></FONT>&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(r)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Disclosure
Controls</U>. The Company has established, maintains and will maintain disclosure controls and procedures (as defined in Rule&nbsp;13a-15(e)&nbsp;of
the Exchange Act) which are designed to ensure that information required to be disclosed by the Company in the reports that it files or
submits under the Exchange Act is recorded, processed, summarized and reported in accordance with the Exchange Act and the rules&nbsp;and
regulations thereunder. The Company has carried out evaluations, and the Company will carry out evaluations, under the supervision and
with the participation of the Company&rsquo;s management, of the effectiveness of the design and operation of the Company&rsquo;s disclosure
controls and procedures in accordance with Rule&nbsp;13a-15 of the Exchange Act;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(s)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Independent
Registered Public Accounting Firm</U>. Ernst&nbsp;&amp; Young LLP, which has audited and reported on certain financial statements of the
Company and its subsidiaries for the years ended December&nbsp;31, 2022 and December&nbsp;31, 2023 is an independent registered public
accounting firm with respect to the Company and its subsidiaries as required by the Securities Act and the Exchange Act and the rules&nbsp;and
regulations of the Commission and the PCAOB;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(t)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Filing
of Prospectus</U>. Each preliminary prospectus filed as part of the Registration Statement as originally filed or as part of any amendment
thereto, or filed pursuant to Rule&nbsp;424 under the Securities Act, complied when so filed in all material respects with the Securities
Act and the applicable rules&nbsp;and regulations of the Commission thereunder;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(u)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Pending
Proceedings and Examinations</U>. The Registration Statement is not the subject of a pending proceeding or examination under Section&nbsp;8(d)&nbsp;or
8(e)&nbsp;of the Securities Act, and the Company is not the subject of a pending proceeding under Section&nbsp;8A of the Securities Act
in connection with the offering of the Securities;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(v)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Anti-Corruption</U>.
None of the Company, its subsidiaries, affiliates, directors or officers has taken any action in furtherance of an offer, payment, promise
to pay, or authorization or approval of the payment or giving or receipt of money, property, gifts or anything else of value, directly
or indirectly, to any &ldquo;government official&rdquo; (including any officer or employee of a government or government-owned or controlled
entity or of a public international organization, or any person acting in an official capacity for or on behalf of any of the foregoing,
or any political party or party official or candidate for political office) to improperly influence official action or secure an improper
advantage or to any person in violation of any applicable anti-corruption laws; the Company and its subsidiaries and affiliates have conducted
their businesses in compliance with applicable anti-corruption laws and have instituted and maintained policies and procedures designed
to promote and achieve compliance with such laws and with the representation and warranties contained in this paragraph, and neither the
Company nor any of its subsidiaries will use, directly or indirectly, the proceeds of the offering in furtherance of an offer, payment,
promise to pay, or authorization of the payment or giving of money, or anything else of value, to any person in violation of any applicable
anti-corruption laws;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></FONT>&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(w)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Investment
Company</U>. The Company is not, and after giving effect to the offering and sale of the Securities and the application of the proceeds
thereof as described in each of the Registration Statement, the Time of Sale Prospectus and the Prospectus will not be, required to register
as an &ldquo;investment company&rdquo; as such term is defined in the Investment Company Act of 1940, as amended;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(x)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Anti-Money
Laundering Laws</U>. The operations of the Company and its subsidiaries are and have been conducted at all times in compliance with all
applicable financial recordkeeping and reporting requirements, including those of the Bank Secrecy Act, as amended by Title III of the
Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism Act of 2001 (&ldquo;<B>USA
PATRIOT Act</B>&rdquo;), and the applicable anti-money laundering statutes of jurisdictions where the Company and its subsidiaries conduct
business, the rules&nbsp;and regulations thereunder and any related or similar rules, regulations or guidelines, issued, administered
or enforced by any governmental agency (collectively, the &ldquo;<B>Anti-Money Laundering Laws</B>&rdquo;), and no action, suit or proceeding
by or before any court or governmental agency, authority or body or any arbitrator involving the Company or any of its subsidiaries with
respect to the Anti-Money Laundering Laws is pending or, to the knowledge of the Company, threatened, except for any such action, suit
or proceeding, individually or in the aggregate, as would not have a material adverse effect on the Company and its subsidiaries, taken
as a whole;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(y)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>OFAC</U>.
(i)&nbsp;None of the Company, its subsidiaries or, to the Company&rsquo;s knowledge, any of their respective officers or directors is
an individual or entity (&ldquo;<B>Person</B>&rdquo;) that is an Embargoed Person; <I>provided</I> that if any subsidiary of the Company
becomes an Embargoed Person pursuant to clause (B)(3)&nbsp;of the definition thereof as a result of a country or territory becoming subject
to any applicable Sanctions program after the Closing Date, such Person shall not be an Embargoed Person so long as the Company is taking
reasonable steps to either obtain an appropriate license for transacting business in such country or territory or to cause such Person
to no longer reside, be organized or chartered or have a place of business in such country or territory and such Person&rsquo;s residing,
being organized or chartered or having a place of business in such country or territory would not be reasonably expected to have a material
adverse effect on the Company and its subsidiaries, taken as a whole;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&ldquo;<B>Embargoed
Person</B>&rdquo; means (A)&nbsp;any country or territory that is the target of a sanctions program administered by U.S. Department of
Treasury&rsquo;s Office of Foreign Assets Control (&ldquo;<B>OFAC</B>&rdquo;) or (B)&nbsp;any Person that (1)&nbsp;is or is owned or controlled
by one or more Persons publicly identified on the most current list of &ldquo;Specially Designated Nationals and Blocked Persons&rdquo;
published by OFAC, (2)&nbsp;is the target of a sanctions program or sanctions list administered by OFAC, the State Department of the United
States, the European Union or His Majesty&rsquo;s Treasury (collectively, &ldquo;<B>Sanctions</B>&rdquo;) or (3)&nbsp;resides, is organized
or chartered, or has a place of business in a country or territory that is the subject of a Sanctions program administered by OFAC that
prohibits dealing with the government of such country or territory (unless such Person has an appropriate license to transact business
in such country or territory or otherwise is permitted to reside, be organized or chartered or maintain a place of business in such country
or territory without violating any Sanctions); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></FONT>&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(iii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Except
as permitted by Sanctions, the Company will not, directly or indirectly, use the proceeds of the offering, or lend, contribute or otherwise
make available such proceeds to any subsidiary, joint venture partner or other Person:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.8in; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(A)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>to
fund or facilitate any activities or business of or with any Person or in any country or territory that, at the time of such funding or
facilitation, is the subject of Sanctions; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.8in; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(B)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>in
any other manner that will result in a violation of Sanctions by any Person (including any Person participating in the offering, whether
as underwriter, advisor, investor or otherwise); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(z)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><I>Cybersecurity;
Data Protection</I>. Except as otherwise disclosed in the Time of Sale Prospectus and the Prospectus, (i)&nbsp;the Company has not been
notified of, and has no knowledge of any security breach or other compromise of or relating to any of the Company&rsquo;s information
technology and computer systems, networks, hardware, software, data (including the data of its customers, employees, suppliers, vendors
and any third party data maintained by or on behalf of the Company), equipment or technology (collectively, &ldquo;<B>IT Systems and Data</B>&rdquo;),
except in the case of this clause (i)&nbsp;as would not, individually or in the aggregate, result in a material adverse effect on the
current or future consolidated financial position, stockholders&rsquo; equity or results of operations of the Company; (ii)&nbsp;the Company
is presently in compliance with applicable laws or statutes relating to the privacy and security of IT Systems and Data and to the protection
of such IT Systems and Data from unauthorized use, access, misappropriation or modification, except as would not, individually or in the
aggregate, result in a material adverse effect on the current or future consolidated financial position, stockholders&rsquo; equity or
results of operations of the Company; and (iii)&nbsp;the Company has implemented backup and disaster recovery technology consistent with
industry standards and practices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(aa)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><I>Taxes</I>.
Except as would not, individually or in the aggregate, have a material adverse effect on the Company and its subsidiaries, taken as a
whole, each of the Company and its subsidiaries has (i)&nbsp;filed all tax returns that are required to be filed by it or has requested
extensions thereof and (ii)&nbsp;paid all taxes required to be paid by it and any other assessment, fine or penalty levied against it,
except for any such tax, assessment, fine or penalty that is currently being contested in good faith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><I>Agreements
to Sell and Purchase</I>. The Company hereby agrees to sell to the several Underwriters, and each Underwriter, upon the basis of the representations
and warranties herein contained, but subject to the terms and conditions hereinafter stated, agrees, severally and not jointly, to purchase
from the Company, at purchase prices as set forth on Schedule I, in the respective principal amounts of Securities as set forth opposite
its name in Schedule II hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><I>Terms
of Offering</I>. The Representatives have advised the Company that the Underwriters will, subject to the provisions hereof and the selling
restrictions disclosed in the Prospectus, make a public offering of their respective proportions of the Securities purchased by the Underwriters
hereunder as soon after the Registration Statement and this Agreement have become effective as in the judgment of the Representatives
is advisable. The Company is further advised by you that the Securities are to be offered to the public upon the terms set forth in the
Prospectus (including the selling and transfer restrictions contained therein).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></FONT>&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.<FONT STYLE="font-size: 10pt"><I>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Payment and Delivery</I>. Payment for the Securities shall be made to the Company in Federal or other funds immediately available
in New York City against delivery of such Securities for the respective accounts of the several Underwriters at 10:00 a.m., New York
City time, on February 26, 2025, or at such other time on the same or such other date as shall be designated in writing by the Representatives.
The time and date of such payment are hereinafter referred to as the &ldquo;<B>Closing Date</B>.&rdquo;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.65in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Payment for the Securities shall be made against
delivery, and the Securities shall be registered in such names and in such denominations as the Representatives shall request in writing
not later than one full business day prior to the Closing Date. The Securities shall be delivered to the Representatives on the Closing
Date for the respective accounts of the several Underwriters, with any transfer taxes payable in connection with the transfer of the Securities
to the Underwriters duly paid, against payment of the purchase price therefor plus accrued interest, if any, to the date of payment and
delivery.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><I>Conditions
to the Underwriters&rsquo; Obligations</I>. The several obligations of the Underwriters to purchase and pay for the Securities on the
Closing Date are subject, in the discretion of the Representatives, to the condition that all representations and warranties and other
statements of the Company in this Agreement are, at and as of the Closing Date, true and correct, the condition that each of them shall
have performed in all material respects all of their respective obligations hereunder theretofore to be performed and to the following
additional conditions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Effectiveness
of Registration Statement; Filing of Prospectus</U><I>. </I>The Registration Statement has become effective and at the Closing Date and
no stop order suspending the effectiveness of the Registration Statement shall have been issued under the Securities Act or proceedings
therefor or pursuant to Section&nbsp;8A under the Securities Act initiated or, to the knowledge of the Company, threatened by the Commission,
and any request on the part of the Commission for additional information shall have been complied with to the reasonable satisfaction
of counsel to the Underwriters. The filings required under Rule&nbsp;424(b)&nbsp;shall have been filed with the Commission in the manner
and within the time period required by Rule&nbsp;424(b)&nbsp;(or a post-effective amendment providing such information shall have been
filed and become effective in accordance with the requirements of Rule&nbsp;430B). The Final Term Sheet (as defined herein) and any other
material required to be filed by the Company pursuant to Rule&nbsp;433(d)&nbsp;under the rules&nbsp;and regulations under the Securities
Act shall have been timely filed;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Opinion
and Negative Assurance Letters of Counsel for the Underwriters</U>. The Underwriters shall have received on the Closing Date an opinion
and negative assurance letter of Davis Polk&nbsp;&amp; Wardwell LLP, counsel for the Underwriters, dated the Closing Date, with respect
to such matters as may be reasonably requested by the Underwriters;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Opinion
of the Company&rsquo;s Internal Counsel</U>. The Underwriters shall have received on the Closing Date an opinion letter of Emily A. Weith,
Vice President, Corporate Legal, Governance, and Assistant Secretary (or such other person who shall be a senior legal officer of the
Company on the Closing Date), dated the Closing Date, in form and substance satisfactory to the Underwriters;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Opinion
and Negative Assurance Letters of Counsel for the Company</U>. The Underwriters shall have received on the Closing Date an opinion letter
of Wachtell, Lipton, Rosen&nbsp;&amp; Katz, outside counsel for the Company, dated the Closing Date, in form and substance satisfactory
to the Underwriters, and a negative assurance letter, dated the Closing Date, in form and substance satisfactory to the Underwriters;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></FONT>&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Accountant&rsquo;s
Comfort Letters</U>. The Underwriters shall have received on each of the date hereof and the Closing Date a letter, dated the date hereof
or the Closing Date, as applicable, in form and substance satisfactory to the Underwriters, from Ernst&nbsp;&amp; Young LLP, independent
public accountants with respect to the Company&rsquo;s consolidated financial statements and certain financial information for the years
ended December&nbsp;31, 2022 and December&nbsp;31, 2023, containing statements and information of the type ordinarily included in accountants&rsquo;
 &ldquo;comfort letters&rdquo; to underwriters with respect to the financial statements and certain financial information contained in
the Time of Sale Prospectus and the Prospectus; <I>provided</I> that the letter delivered on the Closing Date shall use a &ldquo;cut-off
date&rdquo; not earlier than the date hereof;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>No
Material Adverse Change</U><I>. </I>(i)&nbsp;Neither the Company nor any of its subsidiaries shall have sustained since the date of the
latest financial statements included in the Time of Sale Prospectus any loss or interference with its business from fire, explosion, flood
or other calamity, whether or not covered by insurance, or from any labor dispute or court or governmental action, order or decree, otherwise
than as set forth or contemplated in the Registration Statement, the Time of Sale Prospectus and the Prospectus, and (ii)&nbsp;since the
respective dates as of which information is given in the Registration Statement, the Time of Sale Prospectus and the Prospectus, there
shall not have been any change in the consolidated capital stock or any increase in the consolidated long-term debt of the Company and
its subsidiaries, taken as a whole, or any change, or any development involving a prospective change, in or affecting the business, financial
position, shareholders&rsquo; equity or results of operations of the Company and its subsidiaries, taken as a whole, otherwise than as
set forth or contemplated in the Registration Statement, the Time of Sale Prospectus and the Prospectus, the effect of which, in any such
case described in clause <B>&lrm;</B>(i)&nbsp;or <B>&lrm;</B>(ii), is in the reasonable judgment of the Representatives so material and
adverse as to make it impracticable or inadvisable to proceed with the offering or the delivery of the Securities on the terms and in
the manner contemplated in the Registration Statement, the Time of Sale Prospectus and the Prospectus;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(g)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>No
Downgrade</U>. On or after the date of this Agreement (i)&nbsp;no downgrading shall have occurred, nor shall any notice have been given
of any intended or potential downgrading, in the rating accorded the Company (if any) or any of the securities of the Company or any of
its subsidiaries by Moody&rsquo;s Investor Services or Standard&nbsp;&amp; Poor&rsquo;s Ratings Service and (ii)&nbsp;neither organization
shall have publicly announced that it has under surveillance or review, with possible negative implications, its rating of any of the
Company&rsquo;s debt securities;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(h)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Officers&rsquo;
Certificate</U><I>. </I>The Company shall have furnished or caused to be furnished to the Representatives on the Closing Date a certificate
of two officers of the Company, satisfactory to the Representatives as to the accuracy of the representations and warranties of the Company
herein at and as of the Closing Date, as to the performance by the Company of all of its respective obligations hereunder to be performed
at or prior to the Closing Date and as to the matters set forth in <B>&lrm;</B>5(f)&nbsp;and <B>&lrm;</B>5(g); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></FONT>&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Chief
Financial Officer&rsquo;s Certificate</U>. On the date hereof and on the Closing Date, the Company shall have furnished to the Representatives
a certificate, dated the respective date of delivery thereof, of Scott T. Reents, Chief Financial Officer of the Company, in form and
substance satisfactory to the Representatives and covering such matters as the Representatives may reasonably request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">6.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><I>Covenants
of the Company</I>. The Company covenants to each Underwriter as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Compliance
with Securities Regulations and Commission Requests</U>. The Company will comply with the requirements of Rule&nbsp;430B and will notify
the Representatives immediately, and confirm the notice in writing, (i)&nbsp;when any post-effective amendment to the Registration Statement
or new registration statement relating to the Securities shall become effective, or any supplement to the Prospectus or any amended Prospectus
shall have been filed, (ii)&nbsp;of the receipt of any comments from the Commission, (iii)&nbsp;of any request by the Commission for any
amendment to the Registration Statement or the filing of a new registration statement or any amendment or supplement to the Prospectus
or any document incorporated by reference therein or otherwise deemed to be a part thereof or for additional information relating to the
Registration Statement or the Prospectus, (iv)&nbsp;of the issuance by the Commission of any stop order suspending the effectiveness of
the Registration Statement or such new registration statement or of any order preventing or suspending the use of any preliminary prospectus,
or of the suspension of the qualification of the Securities for offering or sale in any jurisdiction, or of the initiation or threatening
of any proceedings for any of such purposes or of any examination pursuant to Section&nbsp;8(e)&nbsp;of the Securities Act concerning
the Registration Statement and (v)&nbsp;if the Company becomes the subject of a proceeding under Section&nbsp;8A of the Securities Act
in connection with the offering of the Securities. The Company will effect the filings required under Rule&nbsp;424(b), in the manner
and within the time period required by Rule&nbsp;424(b), and will take such steps as it deems necessary to ascertain promptly whether
the form of prospectus transmitted for filing under Rule&nbsp;424(b)&nbsp;was received for filing by the Commission and, in the event
that it was not, it will promptly file such prospectus. The Company will make every reasonable effort to prevent the issuance of any stop
order and, if any stop order is issued, to obtain the lifting thereof at the earliest possible moment;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Delivery
of Prospectus</U>. To furnish to the Representatives in New York City, without charge, prior to 10:00 a.m.&nbsp;New York City time on
the second business day next succeeding the date of this Agreement and during the period mentioned in Section&nbsp;6(e)&nbsp;or (f), as
many copies of the Time of Sale Prospectus, the Prospectus, any documents incorporated by reference therein and any supplements and amendments
thereto as the Representatives may reasonably request;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Delivery
of Registration Statement</U>. Before amending or supplementing the Registration Statement, the Time of Sale Prospectus or the Prospectus
during any period when a prospectus relating to the Securities is required to be delivered under the Securities Act, to furnish to the
Representatives a copy of each such proposed amendment or supplement and not to file any such proposed amendment or supplement to which
the Representatives reasonably object, except as may be required by applicable law;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></FONT>&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Issuer
Free Writing Prospectuses</U>. To furnish to the Representatives a copy of each proposed free writing prospectus to be prepared by or
on behalf of, used by, or referred to by the Company and not to use or refer to any proposed free writing prospectus to which the Representatives
reasonably object; <FONT STYLE="background-color: white">not to take any action that would result in an Underwriter or the Company being
required to file with the Commission pursuant to Rule&nbsp;433(d)&nbsp;under the Securities Act a free writing prospectus prepared by
or on behalf of the Underwriter that the Underwriter otherwise would not have been required to file thereunder;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Continued
Compliance with Securities Laws</U>. If the Time of Sale Prospectus is being used to solicit offers to buy the Securities at a time when
the Prospectus is not yet available to prospective purchasers and any event shall occur or condition exist as a result of which it is
necessary to amend or supplement the Time of Sale Prospectus in order to make the statements therein, in the light of the circumstances,
not misleading, <FONT STYLE="background-color: white">any event shall occur or condition exist as a result of which the Time of Sale Prospectus
</FONT>conflicts <FONT STYLE="background-color: white">with the information contained in the Registration Statement then on file, </FONT>or
if, in the opinion of counsel for the Underwriters, it is necessary to amend or supplement the Time of Sale Prospectus to comply with
applicable law, forthwith to prepare, file with the Commission and furnish, at its own expense, to the Underwriters and to any dealer
upon request, either amendments or supplements to the Time of Sale Prospectus so that the statements in the Time of Sale Prospectus as
so amended or supplemented will not, in the light of the circumstances when the Time of Sale Prospectus is delivered to a prospective
purchaser, be misleading or so that the Time of Sale Prospectus, <FONT STYLE="background-color: white">as amended or supplemented, will
no longer conflict with the Registration Statement, or so that the Time of Sale Prospectus, </FONT>as amended or supplemented, will comply
with applicable law; <I>provided</I> that all such amendments or supplements comply with Section&nbsp;6(c)&nbsp;hereof;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Filing
of Amendments</U>. If, during such period after the first date of the public offering of the Securities as in the opinion of counsel for
the Underwriters the Prospectus <FONT STYLE="background-color: white">(or in lieu thereof the notice referred to in Rule&nbsp;173(a)&nbsp;of
the Securities Act) is required by law to be delivered in connection with sales by an </FONT>Underwriters <FONT STYLE="background-color: white">or
dealer</FONT>, any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus in
order to make the statements therein, in the light of the circumstances when the Prospectus <FONT STYLE="background-color: white">(or
in lieu thereof the notice referred to in Rule&nbsp;173(a)&nbsp;of the Securities Act) </FONT>is delivered to a purchaser, not misleading,
or if, in the opinion of counsel for the Underwriters, it is necessary to amend or supplement the Prospectus to comply with applicable
law, forthwith to prepare, file with the Commission and furnish, at its own expense (unless such amendment or supplement shall be made
more than six months after the date of this Agreement, in which case at the sole expense of the Underwriters), to the Underwriters <FONT STYLE="background-color: white">and
to the dealers (whose names and addresses you will furnish to the Company) to which Securities may have been sold by you on behalf of
the Underwriters and to any other dealers upon request</FONT>, either amendments or supplements to the Prospectus so that the statements
in the Prospectus as so amended or supplemented will not, in the light of the circumstances when the Prospectus <FONT STYLE="background-color: white">(or
in lieu thereof the notice referred to in Rule&nbsp;173(a)&nbsp;of the Securities Act) </FONT>is delivered to a purchaser, be misleading
or so that the Prospectus, as amended or supplemented, will comply with applicable law; <I>provided</I> that all such amendments or supplements
comply with Section&nbsp;6(c)&nbsp;hereof;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></FONT>&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(g)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Blue
Sky Qualifications</U>. To endeavor to qualify the Securities for offer and sale under the securities or Blue Sky laws of such jurisdictions
as the Representatives shall reasonably request and to continue such qualifications, if any, in effect so long as required for the underwriting
of the Securities by the Underwriters; <I>provided</I> that the Company shall not be required to qualify as a foreign corporation or to
file a general consent to service of process in any jurisdiction or subject itself to taxation in a jurisdiction in which it is not otherwise
subject;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(h)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><FONT STYLE="background-color: white"><U>Earnings
Statement</U>. To make generally available to the Company&rsquo;s security holders and to you as soon as practicable an earnings statement
covering a period of at least twelve months beginning with the first fiscal quarter of the Company occurring after the date of this Agreement
which shall satisfy the provisions of Section&nbsp;11(a)&nbsp;of the Securities Act and the rules&nbsp;and regulations of the Commission
thereunder;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Fees
and Expenses</U>. Whether or not the transactions contemplated in this Agreement are consummated or this Agreement is terminated, to pay
or cause to be paid the following: (i)&nbsp;the fees, disbursements and expenses of the counsel and accountants for the Company in connection
with the registration and delivery of the Securities under the Securities Act and all other fees or expenses in connection with the preparation
and filing of <FONT STYLE="background-color: white">the Registration Statement, any </FONT>preliminary <FONT STYLE="background-color: white">prospectus,
the Time of Sale Prospectus, the Prospectus, any free writing prospectus prepared by or on behalf of, used by, or referred to by the Company
and amendments and supplements to any of the foregoing, including the filing fees payable to the Commission relating to the Securities
(within the time required by Rule&nbsp;456 (b)(1), if applicable), </FONT>amendments and supplements thereto and the mailing and delivering
of copies thereof to the Underwriters and dealers along with all necessary issue, transfer, stamp, and other similar taxes in connection
therewith and or otherwise in connection with the issuance and sale of the Securities to the Underwriters; (ii)&nbsp;the cost of printing
or producing this Agreement, the Indenture, any Blue Sky survey and any other documents in connection with the offering, purchase, sale
and delivery of the Securities; (iii)&nbsp;all expenses in connection with the qualification of the Securities for offering and sale under
state securities laws as provided in Section&nbsp;8(g)&nbsp;hereof, including the reasonable fees and disbursements of counsel for the
Underwriters in connection with such qualification and in connection with the Blue Sky or legal investment memorandum; (iv)&nbsp;any reasonable
fees charged by securities rating services for rating the Securities; (v)&nbsp;the fees and expenses of the Trustee and any agent of the
Trustee and the fees and disbursements of counsel for any Trustee in connection with the Indenture and the Securities; and <FONT STYLE="background-color: white">(vi)&nbsp;all
filing fees and the reasonable fees and disbursements of counsel to the Underwriters incurred in connection with the review and qualification
of the offering of the Securities by the Financial Industry Regulatory Authority, </FONT> and all other costs and expenses incident to
the performance of their obligations hereunder which are not otherwise specifically provided for in this Section&nbsp;6. It is understood,
however, that, except as provided in this Section&nbsp;6, Section&nbsp;<B>&lrm;</B>7 and Section&nbsp;<B>&lrm;</B>10 hereof, the Underwriters
will pay all of their own costs and expenses, including the fees of their counsel, transfer taxes on the transfer of any of the Securities
by them, and any advertising expenses connected with any offers they may make; each Underwriter agrees to pay the portion of such expenses
represented by such Underwriter&rsquo;s pro rata share (based on the proportion that the principal amount of Securities set forth opposite
each Underwriter&rsquo;s name in Schedule II bears to the aggregate principal amount of Securities set forth opposite the names of all
Underwriters) of the Securities;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></FONT>&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(j)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Regulation
M</U>. Not to take any action prohibited by Regulation M under the Exchange Act in connection with the distribution of the Securities
contemplated hereby;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(k)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Use
of Proceeds</U>. To use the proceeds from the sale of the Securities in the manner described in the Time of Sale Prospectus and the Prospectus;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(l)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Delivery
of Documents</U>. During the period of one year hereafter, the Company will furnish to the Underwriters, as soon as available, a copy
of each of the reports, notices or communications sent to securityholders, if not available on the Commission&rsquo;s Electronic Data
Gathering, Analysis and Retrieval system;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(m)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><FONT STYLE="background-color: white"><U>Compliance
with the Securities Act</U>. The Company has not distributed and, prior to the later to occur of (i)&nbsp;the Closing Date and (ii)&nbsp;the
completion of the distribution of the Securities, will not distribute any material in connection with the offering and sale of the Securities,
other than the Time of Sale Prospectus and the Prospectus or other materials, if any, permitted by the Securities Act, or regulations
promulgated pursuant to the Securities Act, and approved by the parties to this Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(n)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><FONT STYLE="background-color: white"><U>Preparation
of a Final Term Sheet</U>. To prepare a final term sheet relating to the offering of the Securities (a &ldquo;<B>Final Term Sheet</B>&rdquo;),
containing only information that describes the final terms of the Securities or the offering in a form consented to by the </FONT>Underwriters<FONT STYLE="background-color: white">,
and to file such final term sheet within the period required by Rule&nbsp;433(d)(5)(ii)&nbsp;under the Securities Act following the date
the final terms have been established for the offering of the Securities; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(o)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Restriction
on Sale of Securities</U>. The Company also agrees that, without the prior written consent of the Representatives on behalf of the Underwriters,
it will not, during the period beginning on the date hereof and continuing to and including the Closing Date, offer, sell, contract to
sell or otherwise dispose of any debt securities of the Company or warrants to purchase debt securities of the Company substantially similar
to the Securities (other than the sale of the Securities under this Agreement or securities or warrants permitted with the prior written
consent of the Representatives identified in Schedule I with the authorization to release this lock-up on behalf of the Underwriters).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">7.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><I>Covenants
of the Underwriters</I>. <FONT STYLE="background-color: white">Each Underwriter severally covenants with the Company not to take any action
that would result in the Company being required to file with the Commission under Rule&nbsp;433(d)&nbsp;a free writing prospectus prepared
by or on behalf of such Underwriter that otherwise would not be required to be filed by the Company thereunder, but for the action of
the Underwriter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></FONT>&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">8.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><I>Indemnity
and Contribution</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>The
Company will indemnify and hold harmless each Underwriter, its directors, officers and employees, each person, if any, who controls any
Underwriter within the meaning of either Section&nbsp;15 of the Securities Act or Section&nbsp;20 of the Exchange Act, and each affiliate
of any Underwriter within the meaning of Rule&nbsp;405 under the Securities Act, from and against any and all losses, claims, damages
and liabilities, joint or several, to which such Underwriter, director, officer, employee, controlling person or affiliate may become
subject under such Securities Act or otherwise, insofar as such losses, claims, damages or liabilities (or actions in respect thereof)
arise out of or are based upon an untrue statement or alleged untrue statement of a material fact contained in the Registration Statement,
the Time of Sale Prospectus or any amendment or supplement thereto, any free writing prospectus <FONT STYLE="background-color: white">as
defined in Rule&nbsp;433(h)&nbsp;under the Securities Act, any </FONT>Company <FONT STYLE="background-color: white">information that the
Company has filed, or is required to file, pursuant to Rule&nbsp;433(d)&nbsp;under the Securities Act, any &ldquo;road show&rdquo; as
defined in Rule&nbsp;433(h)&nbsp;under the Securities Act (a &ldquo;<B>road show</B>&rdquo;)</FONT>, the Prospectus or any amendment or
supplement thereto, or arise out of or are based upon the omission or alleged omission to state therein a material fact necessary in order
to make the statements therein in the light of the circumstances under which they were made not misleading, and will reimburse each Underwriter,
director, officer, employee, controlling person or affiliate for any legal or other expenses reasonably incurred by such Underwriter,
director, officer, employee or controlling person in connection with investigating or defending any such loss, damage, liability, action
or claim as such expenses are incurred; <I>provided</I>, however, that the Company shall not be liable in any such case to the extent
that any such loss, harm, damage or liability arises out of or is based upon an untrue statement or alleged untrue statement or omission
or alleged omission made in the Prospectus or any free writing prospectus or any amendment or supplement thereto in reliance upon and
in conformity with the Underwriters&rsquo; Information (as defined in Section&nbsp;8(b)&nbsp;below) relating to any Underwriter furnished
to the Company in writing by such Underwriter through the Representatives expressly for use therein, and provided further, that the foregoing
indemnity agreement shall not inure to the benefit of any Underwriter from whom the person asserting any such loss, liability, claim,
damage or expense purchased Securities, or any person controlling such Underwriter, if the Company provides a copy of an amendment or
supplement to the Prospectus or any free writing prospectus as theretofore provided to such Underwriter by the Company (with notice that
such amendment or supplement contains additional or different material information from that previously provided) sufficiently far enough
in advance of the time of sale in order to enable such Underwriter to convey such amendment or supplement to the purchaser of the Securities,
and such amendment or supplement (x)&nbsp;was not conveyed by or on behalf of such Underwriter to such person at or prior to the entry
into the contract of sale of the Securities by such person, and (y)&nbsp;would have cured the defect giving rise to such loss, liability,
claim, damage or expense.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Each
Underwriter will, severally and not jointly, indemnify and hold harmless the Company and its respective directors, officers and employees
and each person, if any, who controls the Company within the meaning of either Section&nbsp;15 of the Securities Act or Section&nbsp;20
of the Exchange Act against any losses, claims, damages or liabilities to which the Company or any of its respective directors, officers,
employees or controlling persons may become subject, under the Securities Act or otherwise, insofar as such losses, claims, damages or
liability (or actions in respect thereof) arise out of or are based upon an untrue statement or alleged untrue statement of a material
fact contained in any Registration Statement, the Time of Sale Prospectus, any preliminary prospectus, free writing prospectus, road show
or the Prospectus, or any amendment or supplement thereto, or arise out of or are based upon the omission or alleged omission to state
therein a material fact necessary in order to make the statements therein not misleading, in each case to the extent, but only to the
extent, that such untrue statement or alleged untrue statement, or omission or alleged omission was made in any Registration Statement,
the Time of Sale Prospectus, any preliminary prospectus, free writing prospectus or the Prospectus, or any such amendment or supplement,
in reliance upon and conformity with written information furnished to the Company by such Underwriter through the Representatives expressly
for use therein; and each Underwriter will reimburse the Company, or any director, officer, employee or controlling person of the Company,
for any legal or other expenses reasonably incurred by the Company, or any such director, officer, employee or controlling person in connection
with investigating, or defending any such loss, damage, liability, action or claim as such expenses are incurred, but only with reference
to the Underwriters&rsquo; Information (defined below) relating to such Underwriter furnished to the Company in writing by such Underwriter
through you expressly for use in the Registration Statement, the Time of Sale Prospectus, any free writing prospectus or the Prospectus
or any amendment or supplement thereto. The Company hereby acknowledges that the only such information are the statements set forth in
the first and second paragraphs under the sub-heading &ldquo;Stabilization and Short Positions,&rdquo; in each case under the caption
 &ldquo;Underwriting&rdquo; in the Time of Sale Prospectus and the Prospectus (collectively, the &ldquo;<B>Underwriters&rsquo; Information</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></FONT>&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Promptly
after receipt by an indemnified party under Sections <B>&lrm;</B>8(a)&nbsp;and <B>&lrm;</B>8(b)&nbsp;above of notice of the commencement
of any action, such indemnified party shall, if a claim in respect thereof is to be made against the indemnifying party under such subsection,
notify the indemnifying party in writing of the commencement thereof; but the omission so to notify the indemnifying party shall not relieve
it from any liability which it may have to any indemnified party except to the extent such omission materially prejudices the indemnifying
party. In case any such action shall be brought against any indemnified party, the indemnifying party shall be entitled to participate
therein and, to the extent that it shall wish, jointly with any other indemnifying party similarly notified, to assume the defense thereof,
with counsel reasonably satisfactory to such indemnified party (who shall not, except with the consent of the indemnified party, be counsel
to the indemnifying party), and, after notice from the indemnifying party to such indemnified party of its election so to assume the defense
thereof, the indemnifying party shall not be liable to such indemnified party under such subsection for any legal expenses of other counsel
or any other expenses, in each case subsequently incurred by such indemnified party, in connection with the defense thereof other than
reasonable costs of investigation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>To
the extent the indemnification provided for in Sections <B>&lrm;</B>8(a)&nbsp;and <B>&lrm;</B>8(b)&nbsp;is unavailable to an indemnified
party or insufficient in respect of any losses, claims, damages or liabilities referred to therein (or actions in respect thereof), then
each indemnifying party under such paragraph, in lieu of indemnifying such indemnified party thereunder, shall contribute to the amount
paid or payable by such indemnified party as a result of such losses, claims, damages or liabilities (i)&nbsp;in such proportion as is
appropriate to reflect the relative benefits received by the Company, on the one hand and the Underwriters on the other hand from the
offering of the Securities or (ii)&nbsp;if the allocation provided by clause <B>&lrm;</B>8(d)(i)&nbsp;above is not permitted by applicable
law or if the indemnified party failed to give notice required under Section&nbsp;<B>&lrm;</B>8(c)&nbsp;above, in such proportion as is
appropriate to reflect not only the relative benefits referred to in clause (i)&nbsp;above but also the relative fault of the Company
on the one hand and of the Underwriters on the second hand in connection with the statements or omissions that resulted in such losses,
claims, damages or liabilities (or actions in respect thereof), as well as any other relevant equitable considerations. The relative benefits
received by the Company on the one hand and the Underwriters on the other hand in connection with the offering of the Securities shall
be deemed to be in the same respective proportions as the net proceeds from the offering of the Securities (before deducting expenses)
received by the Company and the total discounts and commissions received by the Underwriters bear to the aggregate offering price of the
Securities. The relative fault of the Company on the one hand and of the Underwriters on the other hand shall be determined by reference
to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state
a material fact relates to information supplied by the Company or by the Underwriters and the parties&rsquo; relative intent, knowledge,
access to information and opportunity to correct or prevent such statement or omission. The Underwriters&rsquo; respective obligations
to contribute pursuant to this Section&nbsp;<B>&lrm;</B>7 are several in proportion to the respective principal amount of Securities they
have purchased hereunder, and not joint.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></FONT>&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>The
Company and the Underwriters agree that it would not be just or equitable if contribution pursuant to this Section&nbsp;8 were determined
by pro rata allocation (even if the Underwriters were treated as one entity for such purpose) or by any other method of allocation that
does not take account of the equitable considerations referred to in Section&nbsp;8(d). The amount paid or payable by an indemnified party
as a result of the losses, claims, damages and liabilities referred to in Section&nbsp;<B>&lrm;</B>8(d)&nbsp;shall be deemed to include,
subject to the limitations set forth above, any legal or other expenses reasonably incurred by such indemnified party in connection with
investigating or defending any such action or claim. Notwithstanding the provisions of this Section&nbsp;8, no Underwriter shall be required
to contribute any amount in excess of the amount by which the total price at which the Securities underwritten by it and distributed to
the public were offered to the public exceeds the amount of any damages that such Underwriter has otherwise been required to pay by reason
of such untrue or alleged untrue statement or omission or alleged omission. No person guilty of fraudulent misrepresentation (within the
meaning of Section&nbsp;11(f)&nbsp;of the Securities Act) shall be entitled to contribution from any person who was not guilty of such
fraudulent misrepresentation. The remedies provided for in this Section&nbsp;8 are not exclusive and shall not limit any rights or remedies
which may otherwise be available to any indemnified party at law or in equity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>The
indemnifying party under this Section&nbsp;8 shall not be liable for any settlement of any proceeding effected without its written consent
but if settled with such consent or if there be a final judgment for the plaintiff, the indemnifying party agrees to indemnify the indemnified
party against any loss, claim, damage, liability or expense by reason of such settlement or final judgment.&nbsp; Notwithstanding the
foregoing sentence, if at any time an indemnified party shall have requested an indemnifying party to reimburse the indemnified party
for fees and expenses of counsel as contemplated by this Section&nbsp;8, the indemnifying party agrees that it shall be liable for any
settlement of any proceeding effected without its written consent if (i)&nbsp;such settlement is entered into more than 30 days after
receipt by such indemnifying party of the aforesaid request and (ii)&nbsp;such indemnifying party shall not have reimbursed the indemnified
party in accordance with such request or disputed in good faith the indemnified party&rsquo;s entitlement to such reimbursement prior
to the date of such settlement.&nbsp; No indemnifying party shall, without the prior written consent of the indemnified party, effect
any settlement, compromise or consent to the entry of judgment in any pending or threatened action, suit or proceeding in respect of which
any indemnified party is or could have been a party and indemnity was or could have been sought hereunder by such indemnified party, unless
such settlement, compromise or consent (i)&nbsp;includes an unconditional release of such indemnified party from all liability on claims
that are the subject matter of such action, suit or proceeding and (ii)&nbsp;does not include any statements as to or any findings of
fault, culpability or failure to act by or on behalf of any indemnified party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></FONT>&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(g)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>The
indemnity and contribution provisions contained in this Section&nbsp;8 and the representations, warranties and other statements of the
Company contained in this Agreement shall remain operative and in full force and effect regardless of (i)&nbsp;any termination of this
Agreement, (ii)&nbsp;any investigation made by or on behalf of any Underwriter, any person controlling any Underwriter or any affiliate
of any Underwriter or by or on behalf of the Company, its officers or directors or any person controlling the Company and (iii)&nbsp;acceptance
of and payment for any of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">9.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><I>Termination</I>.
The Underwriters may terminate this Agreement by notice given by Representatives to the Company, if after the execution and delivery of
this Agreement and prior to the Closing Date there shall have occurred (i)&nbsp;a suspension of trading of the Company&rsquo;s common
shares by the Commission or the New York Stock Exchange; (ii)&nbsp;a suspension or material limitation in trading in securities generally
on the New York Stock Exchange; (iii)&nbsp;a general moratorium on commercial banking activities in New York declared by either Federal
or New York State authorities; (iv)&nbsp;a material disruption in commercial banking or securities settlement, payment or clearance services
in the United States; or (v)&nbsp;the outbreak or escalation of hostilities or the occurrence of any other calamity or crisis or any material
adverse change in financial markets, if the effect of any such event specified in this clause (v)&nbsp;makes it, in the Representatives&rsquo;
judgment, impracticable or inadvisable to proceed with the offer, sale or delivery of the Securities on the terms and in the manner contemplated
in the Time of Sale Prospectus or the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">10.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><I>Effectiveness;
Defaulting Underwriters</I>. This Agreement shall become effective upon the execution and delivery hereof by the parties hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">If,
on the Closing Date, any one or more of the Underwriters shall fail or refuse to purchase the Securities that it has or they have agreed
to purchase hereunder on such date, and the aggregate principal amount of the Securities which such defaulting Underwriter or Underwriters
agreed but failed or refused to purchase is not more than one-tenth of the aggregate principal amount of the Securities to be purchased
on such date, the other Underwriters shall be obligated severally in the proportions that the principal amount of the Securities set forth
opposite their respective names in Schedule II bears to the aggregate principal amount of the Securities set forth opposite the names
of all such non-defaulting Underwriters, or in such other proportions as the Representatives may specify, to purchase the portion of such
Underwriters&rsquo; Securities which such defaulting Underwriter or Underwriters agreed but failed or refused to purchase on such date;
<I>provided</I> that in no event shall the principal amount of the Securities that any Underwriter has agreed to purchase pursuant to
this Agreement be increased pursuant to this Section&nbsp;&lrm;</FONT>10 by an amount in excess of one-ninth of such principal amount
of the Securities without the written consent of such Underwriter. If, on the Closing Date any Underwriter or Underwriters shall fail
or refuse to purchase Securities and the aggregate principal amount of the Securities with respect to which such default occurs is more
than one-tenth of the aggregate principal amount of the Securities to be purchased on such date, and arrangements satisfactory to the
Representatives, the Company, for the purchase of such Securities are not made within 36 hours after such default, this Agreement shall
terminate without liability on the part of any non-defaulting Underwriter and the Company. In any such case, either the Representatives
or the Company shall have the right to postpone the Closing Date, but in no event for longer than seven days, in order that the required
changes, if any, in the Registration Statement, in the Time of Sale Prospectus, in the Prospectus or in any other documents or arrangements
may be effected. Any action taken under this paragraph shall not relieve any defaulting Underwriter from liability in respect of any default
of such Underwriter under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></FONT>&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If this Agreement shall be terminated by the Underwriters,
or any of them, because of any failure or refusal on the part of the Company to comply with the terms or to fulfill any of the conditions
of this Agreement, or if for any reason the Company shall be unable to perform its obligations under this Agreement, the Company will
reimburse the Underwriters or such Underwriters as have so terminated this Agreement with respect to themselves, severally, for all out-of-pocket
expenses (including the fees and disbursements of their counsel) reasonably incurred by such Underwriters in connection with this Agreement
or the offering contemplated hereunder but the Company shall then be under no further liability to any Underwriter with respect this Agreement
except as provided in Section&nbsp;6(i)&nbsp;and Section&nbsp;8 hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">11.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><I>Entire
Agreement</I>. This Agreement, together with any contemporaneous written agreements and any prior written agreements (to the extent not
superseded by this Agreement) that relate to the offering of the Securities, represents the entire agreement between the Company and the
Underwriters with respect to the preparation of any preliminary prospectus, the Time of Sale Prospectus, the Prospectus, the conduct of
the offering, and the purchase and sale of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">12.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><I>Counterparts</I>.
This Agreement may be executed in two or more counterparts, each of which shall be an original, with the same effect as if the signatures
thereto and hereto were upon the same instrument, and shall become effective when one or more counterparts have been signed by each of
the parties and delivered (by telecopy, electronic delivery or otherwise) to the other parties. Signatures to this Agreement transmitted
by facsimile transmission, by electronic mail (including any electronic signature complying with the U.S. federal ESIGN Act of 2000, Uniform
Electronic Transactions Act or other applicable law, e.g., www. Docusign.com) in &ldquo;<B>portable document format</B>&rdquo; (&ldquo;<B>.pdf</B>&rdquo;)
form, or by any other electronic means intended to preserve the original graphic and pictorial appearance of a document, will have the
same effect as physical delivery of the paper document bearing the original signature.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">13.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><I>Applicable
Law</I>. This Agreement shall be governed by and construed in accordance with the internal laws of the State of New York.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">14.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><I>Headings</I>.
The headings of the sections of this Agreement have been inserted for convenience of reference only and shall not be deemed a part of
this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">15.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><I>Notices</I>.
All communications hereunder shall be in writing and effective only upon receipt and if to the Underwriters shall be delivered, mailed
or sent to the Representatives in care of BofA Securities,&nbsp;Inc., 114 West 47th Street, NY8-114-07-01, New York, New York 10036, Attention:
High Grade Debt Capital Markets Transaction Management/Legal, Fax: 212-901-7881; J.P. Morgan Securities LLC, 383 Madison Avenue, New York,
New York 10179, Attention: Investment Grade Syndicate Desk &ndash; 3<SUP>rd</SUP> Floor, Fax: 212-834-6081; Morgan Stanley&nbsp;&amp;
Co. LLC, 1585 Broadway, 29<SUP>th</SUP> Floor, New York, New York 10036, Attention: Investment Banking Division, Fax: 212-507-8999; Barclays
Capital Inc., 745 Seventh Avenue, New York, New York 10019, Attention: Syndicate Registration, Fax: 646-834-8133; Mizuho Securities USA
LLC, 1271 Avenue of the Americas, New York, New York 10020, Attention: Debt Capital Markets, Email: legalnotices@mizuhogroup.com; and
if to the Company, shall be delivered, mailed or sent to AbbVie Inc., 1 North Waukegan Road, North Chicago,&nbsp;Illinois 60064, Attention:
Treasurer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></FONT>&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><I>Recognition
of the U.S. Special Resolution Regimes</I>. (a)&nbsp;In the event that any Underwriter that is a Covered Entity becomes subject to a proceeding
under a U.S. Special Resolution Regime, the transfer from such Underwriter of this Agreement, and any interest and obligation in or under
this Agreement, will be effective to the same extent as the transfer would be effective under the U.S. Special Resolution Regime if this
Agreement, and any such interest and obligation, were governed by the laws of the United States or a state of the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in">(b)&nbsp;In the event that any Underwriter that is a Covered
Entity or a BHC Act Affiliate of such Underwriter becomes subject to a proceeding under a U.S. Special Resolution Regime, Default Rights
under this Agreement that may be exercised against such Underwriter are permitted to be exercised to no greater extent than such Default
Rights could be exercised under the U.S. Special Resolution Regime if this Agreement were governed by the laws of the United States or
a state of the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of this Section&nbsp;16, &ldquo;</FONT><B>BHC Act Affiliate</B>&rdquo; has the meaning assigned to the term &ldquo;affiliate&rdquo;
in, and shall be interpreted in accordance with, 12 U.S.C. &sect; 1841(k). &ldquo;<B>Covered Entity</B>&rdquo; means any of the following:
(i)&nbsp;a &ldquo;covered entity&rdquo; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &sect; 252.82(b); (ii)&nbsp;a
 &ldquo;covered bank&rdquo; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &sect; 47.3(b); or (iii)&nbsp;a &ldquo;covered
FSI&rdquo; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &sect; 382.2(b). &ldquo;<B>Default Right</B>&rdquo;
has the meaning assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. &sect;&sect; 252.81, 47.2 or 382.1, as
applicable. &ldquo;<B>U.S. Special Resolution Regime</B>&rdquo; means each of (i)&nbsp;the Federal Deposit Insurance Act and the regulations
promulgated thereunder and (ii)&nbsp;Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated
thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">[<I>Signature pages&nbsp;follow</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></FONT>&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;&#8239;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">Very truly yours,</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABBVIE INC.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 47%">/s/ Stefan Geldmeyer</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Stefan Geldmeyer</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: Vice President and Corporate Treasurer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>[</B></FONT><I>Signature
page&nbsp;to the Underwriting Agreement</I><B>]</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Accepted as of the date hereof</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">BofA Securities,&nbsp;Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">J.P. Morgan Securities LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Morgan Stanley&nbsp;&amp; Co. LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Barclays Capital Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Mizuho Securities USA LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Acting severally on behalf of themselves and the
several</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Underwriters named in Schedule II hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BofA Securities,&nbsp;Inc.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 47%">/s/ Douglas Muller</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Douglas Muller</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: Managing Director</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">J.P. Morgan Securities LLC</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 47%">/s/ Som Bhattacharyya</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Som Bhattacharyya</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: Executive Director</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Morgan Stanley&nbsp;&amp; Co. LLC</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 47%">/s/ Thomas Hadley</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Thomas Hadley</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: Managing Director</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Barclays Capital Inc.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 47%">/s/ James Gutow</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: James Gutow</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: Managing Director</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>[</B></FONT><I>Signature
page&nbsp;to the Underwriting Agreement</I><B>]</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mizuho Securities USA LLC</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 47%">/s/ Joseph Santaniello</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Joseph Santaniello</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: Managing Director</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>[</B></FONT><I>Signature
page&nbsp;to the Underwriting Agreement</I><B>]</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>SCHEDULE I</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="padding-bottom: 10pt; vertical-align: bottom; width: 50%; padding-right: 5.75pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">Representatives:</FONT></TD>
    <TD STYLE="vertical-align: top; width: 50%; padding-right: 5.75pt; padding-bottom: 10pt; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.25in; padding-bottom: 10pt; padding-right: 5.75pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">Representatives
    to release lock-up under Section 6(n):</FONT></TD>
    <TD STYLE="padding-bottom: 10pt; padding-right: 5.75pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">BofA Securities, Inc.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">J.P. Morgan Securities LLC</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">Morgan Stanley &amp; Co. LLC</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Barclays Capital Inc.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Mizuho Securities USA LLC</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 10pt; padding-right: 5.75pt">
    <P STYLE="text-indent: -0.125in; padding-left: 0.25in; padding-bottom: 10pt; padding-right: 5.75pt; font-size: 10pt">Representatives authorized to appoint
    counsel under Section 8(c):</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.2in">&nbsp;</P></TD>
    <TD STYLE="padding-bottom: 10pt; padding-right: 5.75pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">BofA Securities, Inc.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">J.P. Morgan Securities LLC</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">Morgan Stanley &amp; Co. LLC</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Barclays Capital Inc.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Mizuho Securities USA LLC</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.75pt; padding-bottom: 10pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">Indenture:</FONT></TD>
    <TD STYLE="padding-right: 5.75pt; padding-bottom: 10pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">Indenture dated as of November 8, 2012, as supplemented by Supplemental Indenture No. 11 to be dated February 26, 2025 in each case between the Company and the Trustee</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.75pt; padding-bottom: 10pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">Trustee:</FONT></TD>
    <TD STYLE="padding-right: 5.75pt; padding-bottom: 10pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">U.S. Bank Trust Company, National Association</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.75pt; padding-bottom: 10pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">Registration Statement File No.:</FONT></TD>
    <TD STYLE="padding-right: 5.75pt; padding-bottom: 10pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">333-284980</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.75pt; padding-bottom: 10pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">Time of Sale Prospectus:</FONT></TD>
    <TD STYLE="padding-bottom: 10pt; padding-right: 5.75pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 16.75pt; text-indent: -16.75pt">1.&#8239;&#8239;&#8239;&#8239;&#8239;Basic Prospectus dated February
14, 2025 relating to the Shelf Securities</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 16.75pt; text-indent: -16.75pt">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 16.75pt; text-indent: -16.75pt">2.<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>The preliminary prospectus supplement dated February 18, 2025 relating to the Securities</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 16.75pt; text-indent: -16.75pt">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 16.75pt; text-indent: -16.75pt">3.&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-family: Times New Roman, Times, Serif">    </FONT>Free writing prospectus dated February 18, 2025, containing a description of certain terms filed by the Company under Rule 433(d)
    of the Securities Act</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 16.75pt; text-indent: -16.75pt"></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.75pt; padding-bottom: 10pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">Securities to be Purchased:</FONT></TD>
    <TD STYLE="padding-bottom: 10pt; padding-right: 5.75pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">4.650% Senior Notes due 2028</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">4.875% Senior Notes due 2030</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">5.200% Senior Notes due 2035</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">5.600% Senior Notes due 2055</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.75pt; padding-bottom: 10pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">Aggregate Principal Amount:</FONT></TD>
    <TD STYLE="padding-bottom: 10pt; padding-right: 5.75pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">$1,250,000,000 4.650% Senior Notes due 2028</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">$1,000,000,000 4.875% Senior Notes due 2030</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">$1,000,000,000 5.200% Senior Notes due 2035</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">$750,000,000 5.600% Senior Notes due 2055</P></TD></TR>
  </TABLE>

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 25; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">S-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></FONT>&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-bottom: 10pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">Purchase Price:</FONT></TD>
    <TD STYLE="width: 50%; padding-bottom: 10pt; font-size: 10pt"><FONT STYLE="font-size: 10pt"><BR>
99.617% of the principal amount of the 4.650% Senior Notes due 2028<BR>
99.558% of the principal amount of the 4.875% Senior Notes due 2030<BR>
99.407% of the principal amount of the 5.200% Senior Notes due 2035<BR>
98.875% of the principal amount of the 5.600% Senior Notes due 2055</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 10pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">Maturity:</FONT></TD>
    <TD STYLE="padding-bottom: 10pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">4.650% Senior Notes due 2028: March 15, 2028</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">4.875% Senior Notes due 2030: March 15, 2030</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">5.200% Senior Notes due 2035: March 15, 2035</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">5.600% Senior Notes due 2055: March 15, 2055&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 10pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">Interest Rate:</FONT></TD>
    <TD STYLE="padding-bottom: 10pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">4.650% Senior Notes due 2028: 4.650% per annum, accruing
    from February 26, 2025</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">4.875% Senior Notes due 2030: 4.875% per annum, accruing
    from February 26, 2025</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">5.200% Senior Notes due 2035: 5.200% per annum, accruing
    from February 26, 2025</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">5.600% Senior Notes due 2055: 5.600% per annum, accruing
    from February 26, 2025</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 10pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">Interest Payment Dates:</FONT></TD>
    <TD STYLE="padding-bottom: 10pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">4.650% Senior Notes due 2028: March 15 and September
    15, commencing September 15, 2025</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">4.875% Senior Notes due 2030: March 15 and September
    15, commencing September 15, 2025</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">5.200% Senior Notes due 2035: March 15 and September
    15, commencing September 15, 2025</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">5.600% Senior Notes due 2055: March 15 and September
    15, commencing September 15, 2025</P></TD></TR>
  </TABLE>
<P STYLE="margin: 0">
<P STYLE="margin: 0"></P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">S-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT>&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.75pt; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Closing Date and Time:</FONT></TD>
    <TD STYLE="padding-right: 5.75pt; width: 50%"><P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">February 26, 2025, 10:00 a.m.</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.75pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Closing Location:</FONT></TD>
    <TD STYLE="padding-right: 5.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Davis Polk&nbsp;&amp; Wardwell LLP<BR>
450 Lexington Avenue<BR>
New York, New York 10017</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.75pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address for Notices to Underwriters:</FONT></TD>
    <TD STYLE="padding-right: 5.75pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">BofA Securities,&nbsp;Inc.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">114 West 47th Street</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">NY8-114-07-01</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">New York, New York 10036</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attention: High Grade Debt Capital Markets</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Transaction Management/Legal</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Fax: 212-901-7881;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">J.P. Morgan Securities LLC</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">383 Madison Avenue</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">New York, New York 10179</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attention: Investment Grade Syndicate Desk &ndash; 3<SUP>rd</SUP> Floor</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Fax: 212-834-6081;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Morgan Stanley&nbsp;&amp; Co. LLC</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">1585 Broadway, 29<SUP>th</SUP> Floor</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">New York, New York 10036</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Attention:
    </FONT>Investment Banking Division</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Fax: 212-507-8999;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Barclays Capital Inc.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">745 Seventh Ave</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">New York, New York 10019</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attention: Syndicate Registration</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Fax: 646-834-8133;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Mizuho Securities USA LLC</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">1271 Avenue of the Americas</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">New York, New York 10020</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attention: Debt Capital Markets</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Email: legalnotices@mizuhogroup.com</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.75pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address for Notices to the Company:</FONT></TD>
    <TD STYLE="padding-right: 5.75pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">AbbVie Inc.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">1 North Waukegan Road</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">North Chicago,&nbsp;Illinois 60064</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attention: Treasurer</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">S-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT>&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 6.5in"><B>SCHEDULE II</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center; white-space: nowrap; font-size: 10pt; font-weight: bold">Underwriter</TD><TD STYLE="text-align: center; white-space: nowrap; padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; white-space: nowrap; border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold">Principal Amount of 2028<BR>
 Notes to be Purchased</TD><TD STYLE="text-align: center; white-space: nowrap; padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; white-space: nowrap; padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; white-space: nowrap; border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold">Principal Amount of 2030 <BR>
Notes to be Purchased</TD><TD STYLE="text-align: center; white-space: nowrap; padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; white-space: nowrap; padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; white-space: nowrap; border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold">Principal Amount of 2035 <BR>
Notes to be Purchased</TD><TD STYLE="text-align: center; white-space: nowrap; padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; white-space: nowrap; padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; white-space: nowrap; border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold">Principal Amount of 2055 <BR>
Notes to be Purchased</TD><TD STYLE="text-align: center; white-space: nowrap; padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; width: 36%; font-size: 10pt; text-align: left; text-indent: 0in">BofA Securities, Inc.&#9;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 13%; font-size: 10pt; text-align: right">176,250,000</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 13%; font-size: 10pt; text-align: right">141,000,000</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 13%; font-size: 10pt; text-align: right">141,000,000</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 13%; font-size: 10pt; text-align: right">105,750,000</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="white-space: nowrap; font-size: 10pt; text-align: left; text-indent: 0in">J.P. Morgan Securities LLC&#9;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">176,250,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">141,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">141,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">105,750,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; font-size: 10pt; text-align: left; text-indent: 0in">Morgan Stanley &amp; Co. LLC&#9;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">176,250,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">141,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">141,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">105,750,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="white-space: nowrap; font-size: 10pt; text-align: left; text-indent: 0in">Barclays Capital Inc. &#9;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">63,125,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">50,500,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">50,500,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">37,875,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; font-size: 10pt; text-align: left; text-indent: 0in">Mizuho Securities USA LLC&#9;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">63,125,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">50,500,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">50,500,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">37,875,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="white-space: nowrap; font-size: 10pt; text-align: left; text-indent: 0in">BNP Paribas Securities Corp. &#9;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">63,125,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">50,500,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">50,500,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">37,875,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; font-size: 10pt; text-align: left; text-indent: 0in">Citigroup Global Markets Inc. &#9;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">63,125,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">50,500,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">50,500,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">37,875,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="white-space: nowrap; font-size: 10pt; text-align: left; text-indent: 0in">Deutsche Bank Securities Inc. &#9;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">63,125,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">50,500,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">50,500,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">37,875,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; font-size: 10pt; text-align: left; text-indent: 0in">Goldman Sachs &amp; Co. LLC&#9;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">63,125,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">50,500,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">50,500,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">37,875,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="white-space: nowrap; font-size: 10pt; text-align: left; text-indent: 0in">HSBC Securities (USA) Inc. &#9;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">63,125,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">50,500,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">50,500,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">37,875,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; font-size: 10pt; text-align: left; text-indent: 0in">SG Americas Securities, LLC&#9;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">63,125,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">50,500,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">50,500,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">37,875,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="white-space: nowrap; font-size: 10pt; text-align: left; text-indent: 0in">Wells Fargo Securities, LLC&#9;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">63,125,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">50,500,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">50,500,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">37,875,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; font-size: 10pt; text-align: left; text-indent: 0in">Lloyds Securities Inc. &#9;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">23,125,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">18,500,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">18,500,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">13,875,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="white-space: nowrap; font-size: 10pt; text-align: left; text-indent: 0in">MUFG Securities Americas Inc. &#9;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">23,125,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">18,500,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">18,500,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">13,875,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; font-size: 10pt; text-align: left; text-indent: 0in">Santander US Capital Markets LLC&#9;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">23,125,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">18,500,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">18,500,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">13,875,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="white-space: nowrap; font-size: 10pt; text-align: left; text-indent: 0in">TD Securities (USA) LLC&#9;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">23,125,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">18,500,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">18,500,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">13,875,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; font-size: 10pt; text-align: left; text-indent: 0in">U.S. Bancorp Investments, Inc. &#9;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">23,125,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">18,500,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">18,500,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">13,875,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="white-space: nowrap; font-size: 10pt; text-align: left; text-indent: 0in">Siebert Williams Shank &amp; Co., LLC&#9;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">12,500,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">10,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">10,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">7,500,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; font-size: 10pt; text-align: left; text-indent: 0in">Bancroft Capital, LLC&#9;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">6,250,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">5,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">5,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">3,750,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="white-space: nowrap; font-size: 10pt; text-align: left; text-indent: 0in">Cabrera Capital Markets LLC&#9;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">6,250,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">5,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">5,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">3,750,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; font-size: 10pt; text-align: left; text-indent: 0in">Independence Point Securities LLC&#9;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">6,250,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">5,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">5,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">3,750,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="white-space: nowrap; padding-bottom: 1pt; font-size: 10pt; text-align: left; text-indent: 0in">R. Seelaus &amp; Co., LLC&#9;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">6,250,000</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">5,000,000</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">5,000,000</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">3,750,000</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: center; text-indent: 0in">Total</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">1,250,000,000</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">1,000,000,000</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">1,000,000,000</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">750,000,000</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 28; Options: NewSection Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">S-2-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></FONT>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>abbv-20250218.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.25b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aA5w7xRiXgen8uLa3ZcWaSP2bOdzZR+mYkxtmB9bckK7ykiHZ8N9iD3dlfWgV4M -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:abbv="http://abbvie.com/20250218" elementFormDefault="qualified" targetNamespace="http://abbvie.com/20250218">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://abbvie.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="abbv-20250218_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="abbv-20250218_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="abbv-20250218_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://xbrl.sec.gov/exch/2023" schemaLocation="https://xbrl.sec.gov/exch/2023/exch-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
    <element id="abbv_SeniorNotes0.750Percentdue2027Member" name="SeniorNotes0.750Percentdue2027Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="abbv_SeniorNotes2.125Percentdue2028Member" name="SeniorNotes2.125Percentdue2028Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="abbv_SeniorNotes2.625Percentdue2028Member" name="SeniorNotes2.625Percentdue2028Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="abbv_SeniorNotes2.125Percentdue2029Member" name="SeniorNotes2.125Percentdue2029Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="abbv_SeniorNotes1.250Percentdue2031Member" name="SeniorNotes1.250Percentdue2031Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>abbv-20250218_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.25b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://abbvie.com/role/Cover" xlink:href="abbv-20250218.xsd#Cover" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://abbvie.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems" xlink:label="loc_deiDocumentInformationLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityListingsTable" xlink:label="loc_deiEntityListingsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityListingsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_deiEntityListingsTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="abbv-20250218.xsd#abbv_SeniorNotes0.750Percentdue2027Member" xlink:label="loc_abbvSeniorNotes0.750Percentdue2027Member_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_abbvSeniorNotes0.750Percentdue2027Member_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="abbv-20250218.xsd#abbv_SeniorNotes2.125Percentdue2028Member" xlink:label="loc_abbvSeniorNotes2.125Percentdue2028Member_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_abbvSeniorNotes2.125Percentdue2028Member_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="abbv-20250218.xsd#abbv_SeniorNotes2.625Percentdue2028Member" xlink:label="loc_abbvSeniorNotes2.625Percentdue2028Member_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_abbvSeniorNotes2.625Percentdue2028Member_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="abbv-20250218.xsd#abbv_SeniorNotes2.125Percentdue2029Member" xlink:label="loc_abbvSeniorNotes2.125Percentdue2029Member_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_abbvSeniorNotes2.125Percentdue2029Member_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="abbv-20250218.xsd#abbv_SeniorNotes1.250Percentdue2031Member" xlink:label="loc_abbvSeniorNotes1.250Percentdue2031Member_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_abbvSeniorNotes1.250Percentdue2031Member_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityListingsExchangeAxis" xlink:label="loc_deiEntityListingsExchangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_deiEntityListingsTable" xlink:to="loc_deiEntityListingsExchangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_ExchangeDomain" xlink:label="loc_deiExchangeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiEntityListingsExchangeAxis" xlink:to="loc_deiExchangeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_ExchangeDomain" xlink:label="loc_deiExchangeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiEntityListingsExchangeAxis" xlink:to="loc_deiExchangeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/exch/2023/exch-2023.xsd#exch_XNYS" xlink:label="loc_exchXNYS_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiExchangeDomain" xlink:to="loc_exchXNYS_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/exch/2023/exch-2023.xsd#exch_XCHI" xlink:label="loc_exchXCHI_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiExchangeDomain" xlink:to="loc_exchXCHI_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentType_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiAmendmentFlag_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiAmendmentDescription_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentRegistrationStatement_90" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentAnnualReport_90" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentQuarterlyReport_90" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentTransitionReport_90" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentShellCompanyReport_90" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_90" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentPeriodStartDate_90" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentPeriodEndDate_90" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_90" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_90" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_90" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityFileNumber_90" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityRegistrantName_90" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityCentralIndexKey_90" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityPrimarySicNumber_90" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_90" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_90" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressAddressLine1_90" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressAddressLine2_90" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressAddressLine3_90" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressCityOrTown_90" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_90" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressCountry_90" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_90" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiCountryRegion_90" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiCityAreaCode_90" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiLocalPhoneNumber_90" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiExtension_90" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiWrittenCommunications_90" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSolicitingMaterial_90" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiPreCommencementTenderOffer_90" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_90" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSecurity12bTitle_90" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiNoTradingSymbolFlag_90" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiTradingSymbol_90" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSecurityExchangeName_90" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSecurity12gTitle_90" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSecurityReportingObligation_90" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiAnnualInformationForm_90" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_90" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_90" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityVoluntaryFilers_90" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_90" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_90" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityFilerCategory_90" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntitySmallBusiness_90" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_90" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityExTransitionPeriod_90" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentAccountingStandard_90" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_90" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityShellCompany_90" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityPublicFloat_90" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_90" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_90" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_90" xlink:type="arc" order="57" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>abbv-20250218_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.25b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityListingsExchangeAxis" xlink:label="dei_EntityListingsExchangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityListingsExchangeAxis" xlink:to="dei_EntityListingsExchangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityListingsExchangeAxis_lbl" xml:lang="en-US">Entity Listings, Exchange [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/exch/2023/exch-2023.xsd#exch_XNYS" xlink:label="exch_XNYS" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="exch_XNYS" xlink:to="exch_XNYS_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="exch_XNYS_lbl" xml:lang="en-US">NEW YORK STOCK EXCHANGE, INC. [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/exch/2023/exch-2023.xsd#exch_XCHI" xlink:label="exch_XCHI" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="exch_XCHI" xlink:to="exch_XCHI_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="exch_XCHI_lbl" xml:lang="en-US">NYSE CHICAGO, INC. [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="abbv-20250218.xsd#abbv_SeniorNotes0.750Percentdue2027Member" xlink:label="abbv_SeniorNotes0.750Percentdue2027Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abbv_SeniorNotes0.750Percentdue2027Member" xlink:to="abbv_SeniorNotes0.750Percentdue2027Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="abbv_SeniorNotes0.750Percentdue2027Member_lbl" xml:lang="en-US">Senior Notes 0. 750 Percentdue 2027 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="abbv-20250218.xsd#abbv_SeniorNotes2.125Percentdue2028Member" xlink:label="abbv_SeniorNotes2.125Percentdue2028Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abbv_SeniorNotes2.125Percentdue2028Member" xlink:to="abbv_SeniorNotes2.125Percentdue2028Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="abbv_SeniorNotes2.125Percentdue2028Member_lbl" xml:lang="en-US">Senior Notes 2. 125 Percentdue 2028 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="abbv-20250218.xsd#abbv_SeniorNotes2.625Percentdue2028Member" xlink:label="abbv_SeniorNotes2.625Percentdue2028Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abbv_SeniorNotes2.625Percentdue2028Member" xlink:to="abbv_SeniorNotes2.625Percentdue2028Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="abbv_SeniorNotes2.625Percentdue2028Member_lbl" xml:lang="en-US">Senior Notes 2. 625 Percentdue 2028 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="abbv-20250218.xsd#abbv_SeniorNotes2.125Percentdue2029Member" xlink:label="abbv_SeniorNotes2.125Percentdue2029Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abbv_SeniorNotes2.125Percentdue2029Member" xlink:to="abbv_SeniorNotes2.125Percentdue2029Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="abbv_SeniorNotes2.125Percentdue2029Member_lbl" xml:lang="en-US">Senior Notes 2. 125 Percentdue 2029 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="abbv-20250218.xsd#abbv_SeniorNotes1.250Percentdue2031Member" xlink:label="abbv_SeniorNotes1.250Percentdue2031Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abbv_SeniorNotes1.250Percentdue2031Member" xlink:to="abbv_SeniorNotes1.250Percentdue2031Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="abbv_SeniorNotes1.250Percentdue2031Member_lbl" xml:lang="en-US">Senior Notes 1. 250 Percentdue 2031 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityListingsTable" xlink:label="dei_EntityListingsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityListingsTable" xlink:to="dei_EntityListingsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityListingsTable_lbl" xml:lang="en-US">Entity Listings [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentInformationLineItems_lbl" xml:lang="en-US">Document Information [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>abbv-20250218_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.25b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://abbvie.com/role/Cover" xlink:href="abbv-20250218.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://abbvie.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityListingsTable" xlink:label="loc_deiEntityListingsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityListingsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems" xlink:label="loc_deiDocumentInformationLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityListingsTable" xlink:to="loc_deiDocumentInformationLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityListingsTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="abbv-20250218.xsd#abbv_SeniorNotes0.750Percentdue2027Member" xlink:label="loc_abbvSeniorNotes0.750Percentdue2027Member" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_abbvSeniorNotes0.750Percentdue2027Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="abbv-20250218.xsd#abbv_SeniorNotes2.125Percentdue2028Member" xlink:label="loc_abbvSeniorNotes2.125Percentdue2028Member" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_abbvSeniorNotes2.125Percentdue2028Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="abbv-20250218.xsd#abbv_SeniorNotes2.625Percentdue2028Member" xlink:label="loc_abbvSeniorNotes2.625Percentdue2028Member" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_abbvSeniorNotes2.625Percentdue2028Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="abbv-20250218.xsd#abbv_SeniorNotes2.125Percentdue2029Member" xlink:label="loc_abbvSeniorNotes2.125Percentdue2029Member" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_abbvSeniorNotes2.125Percentdue2029Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="abbv-20250218.xsd#abbv_SeniorNotes1.250Percentdue2031Member" xlink:label="loc_abbvSeniorNotes1.250Percentdue2031Member" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_abbvSeniorNotes1.250Percentdue2031Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityListingsExchangeAxis" xlink:label="loc_deiEntityListingsExchangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityListingsTable" xlink:to="loc_deiEntityListingsExchangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_ExchangeDomain" xlink:label="loc_deiExchangeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityListingsExchangeAxis" xlink:to="loc_deiExchangeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/exch/2023/exch-2023.xsd#exch_XNYS" xlink:label="loc_exchXNYS" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiExchangeDomain" xlink:to="loc_exchXNYS" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/exch/2023/exch-2023.xsd#exch_XCHI" xlink:label="loc_exchXCHI" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiExchangeDomain" xlink:to="loc_exchXCHI" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45058482653248">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Feb. 18, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Feb. 18,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-35565<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ABBVIE
INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001551152<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">32-0375147<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1
North Waukegan Road<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">North
Chicago<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">IL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">60064-6400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">847<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">932-7900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member] | NEW YORK STOCK EXCHANGE, INC. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Stock, $0.01 Par Value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ABBV<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member] | NYSE CHICAGO, INC. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.01 Par Value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ABBV<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">CHX<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=abbv_SeniorNotes0.750Percentdue2027Member', window );">Senior Notes 0. 750 Percentdue 2027 [Member] | NEW YORK STOCK EXCHANGE, INC. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.750%
    Senior Notes due 2027<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ABBV27<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=abbv_SeniorNotes2.125Percentdue2028Member', window );">Senior Notes 2. 125 Percentdue 2028 [Member] | NEW YORK STOCK EXCHANGE, INC. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">2.125%
    Senior Notes Due 2028<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ABBV28<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=abbv_SeniorNotes2.625Percentdue2028Member', window );">Senior Notes 2. 625 Percentdue 2028 [Member] | NEW YORK STOCK EXCHANGE, INC. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">2.625%
    Senior Notes Due 2028<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ABBV28B<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=abbv_SeniorNotes2.125Percentdue2029Member', window );">Senior Notes 2. 125 Percentdue 2029 [Member] | NEW YORK STOCK EXCHANGE, INC. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">2.125%
    Senior Notes due 2029<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ABBV29<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=abbv_SeniorNotes1.250Percentdue2031Member', window );">Senior Notes 1. 250 Percentdue 2031 [Member] | NEW YORK STOCK EXCHANGE, INC. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.250%
    Senior Notes due 2031<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ABBV31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityListingsExchangeAxis=exch_XNYS">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityListingsExchangeAxis=exch_XNYS</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityListingsExchangeAxis=exch_XCHI">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityListingsExchangeAxis=exch_XCHI</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=abbv_SeniorNotes0.750Percentdue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=abbv_SeniorNotes0.750Percentdue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=abbv_SeniorNotes2.125Percentdue2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=abbv_SeniorNotes2.125Percentdue2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=abbv_SeniorNotes2.625Percentdue2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=abbv_SeniorNotes2.625Percentdue2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=abbv_SeniorNotes2.125Percentdue2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=abbv_SeniorNotes2.125Percentdue2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=abbv_SeniorNotes1.250Percentdue2031Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=abbv_SeniorNotes1.250Percentdue2031Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( ,M*4UH'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " #+2E-:%L.' >X    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+/
M2L0P$(=?17)O)\FJ8.CVHGA2$%Q0O(5D=C=L\X=DI-VWMZV[740?P&-F?OGF
M&YC&)&5BQI<<$V9R6*X&WX6B3%JS/5%2 ,7LT>M2CXDP-K<Q>TWC,^\@:7/0
M.P3)^2UX)&TU:9B 55J(K&VL42:CIIA/>&L6?/K,W0RS!K!#CX$*B%H :Z>)
MZ3AT#5P $XPP^_)=0+L0Y^J?V+D#[)0<BEM2?=_7_6K.C3L(>']^>IW7K5PH
MI(/!\5=QBHX)U^P\^6UU_[!Y9*WD\J;BLA)W&W&MI%22?TRN/_PNPCY:MW7_
MV/@LV#;PZR[:+U!+ P04    " #+2E-:F5R<(Q &  "<)P  $P   'AL+W1H
M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03<VEVV[29A.U.
M'X416(UL>621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X
M8-DOV]:[MR_>X%<R)!%!,!FGK_# "J5,7K5::0##.'W)$Q+#W(*+"$MX%,O6
M7.!;&B\CUNJTV]U6A&ELH1A'9&!]7BQH0-!445IO7R"TY1\S^!7+5(UEHP$3
M5T$FN8BT\OELQ?S:WCYES^DZ'3*!;C ;6"!_SF^GY$Y:B.%4PL3 :F<_5FO'
MT=)(@(+)?90%NDGVH],5"#(-.SJ=6,YV?/;$[9^,RMIT-&T:X./Q>#BVR]*+
M<!P$X%&[GL*=]&R_I$$)M*-IT&38]MJND::JC5-/T_=]W^N;:)P*C5M/TVMW
MW=..B<:MT'@-OO%/A\.NB<:KT'3K:28G_:YKI.D6:$)&X^MZ$A6UY4#3( !8
M<';6S-(#EEXI^G64&MD=N]U!7/!8[CF)$?[&Q036:=(9EC1&<IV0!0X -\31
M3%!\KT&VBN#"DM)<D-;/*;50&@B:R('U1X(AQ=RO_?67N\FD,WJ=?3K.:Y1_
M::L!I^V[F\^3_'/HY)^GD]=-0LYPO"P)\?LC6V&')VX[$W(Z'&="?,_V]I&E
M)3+/[_D*ZTX\9Q]6EK!=S\_DGHQR([O=]EA]]D]';B/7J<"S(M>41B1%G\@M
MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7
MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V<
M/!T3$LV4"P9!AI<D)A*I.7Y-2!/^*Z7:_IS30/"4+R3Z2I&/:;,CIW0FS>@S
M&L%&KQMUAVC2/'K^!?F<-0H<D1L= F<;LT8AA&F[\!ZO)(Z:K<(1*T(^8ADV
M&G*U%H&V<:F$8%H2QM%X3M*T$?Q9K#63/F#([,V1=<[6D0X1DEXW0CYBSHN0
M$;\>ACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0'
MHYI9";V$5FJ?JH<T/J@>,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y
M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RS<C'5*^3*=@Y
MG\#L_6@^GO'M^MDDA*^:62TC%I!+@;-!)+C\B\KP*L0)Z&1;)0G+5--E-XH2
MGD(;;NE3]4J5U^6ON2BX/%ODZ:^A=#XLS_D\7^>TS0LS0[=R2^JVE+ZU)CA*
M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D*
MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-#
MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B
M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P
MOFH]M!5.S_Y9K<B?#!%.%@L22&.4%Z9*HO,94[[G*TG$53B_13.V$I<8O./F
MQW%.4[@2=K8/ C*YNSFI>F4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W
MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2
MD 83 <V4R43P H)DIAR F/H+O?(,N2D5SJT^.7]%+(.&3E[2)1(4BK ,!2$7
M<N/O[Y-J=XS7^BR!;814,F35%\I#B<$],W)#V%0E\Z[:)@N%V^)4S;L:OB9@
M2\-Z;ITM)__;7M0]M!<]1O.CF> >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F
M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+
M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5
M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0    (
M ,M*4UK)>'-A4@8  %LF   8    >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL
MM9IK4^)(%(:_^RNZV$OM5BGD"CBK5BFB4LX@)>XXLU/SH4D:2)FDV4[CI6I_
M_)X.F&:<<!J5^$$22+^\Z7-Y.B$'#US<95/&)'E,XC0[K$VEG'UH-+)@RA*:
MU?F,I?#)F(N$2M@5DT8V$XR&^: D;CB6U6PD-$IK1P?Y>P-Q=,#G,HY2-A D
MFR<)%4\G+.8/AS6[]OS&=3292O5&X^A@1B=LR.3?LX& O4:A$D8)2[.(IT2P
M\6'MV/YPXC?5@/R(SQ%[R%:VB3J5$>=W:J<7'M8LY8C%+)!*@L++/>NP.%9*
MX./?I6BM^$XU<'7[6?TL/WDXF1'-6(?'MU$HIX>U=HV$;$SGL;SF#Q=L>4*^
MT@MXG.7_R</R6*M&@GDF>;(<# Z2*%V\TL?E1*P,<+TU YSE "?WO?BBW.4I
ME?3H0/ '(M31H*8V\E/-1X.Y*%51&4H!GT8P3AYU^#T3!PT)4NJ-1K <=K(8
MYJP9=L9&=6*W=XEC.?Z/PQO@H+#A%#:<7,]=HW?*@SG$6I)>NL@T%;%O'^$H
MTI,LR;Z765Q(>N62*IT_9#,:L,,:Y&O&Q#VK'?W^B]VT_D(,NX5A%U/7AF^>
M9JS,'#Z\O7>)F/ *$QZJ<@P.PMS%64PG92[P\6,:9PSQX1<^_,TF8\!$Q$/2
M34,"V5@Z+[A2D5>FQ&H6UIJH8#>5D7PB9U',2'^>C,J3'=>P+'O/]?TFYJ=5
M^&EMXN>:3:),"@ISUJ=)Z43A.L<G)Y][W9U>OU-'7+4+5^U-7'4@AH+&4(0A
M>R27[*G,%ZYDP63YOFW[#F)KO["UOXFM&_I(>B%XB\91L&@-ZT.)*[K.GN6V
M?-MK(?9L2S=/:Q.#O33@8L9%[FV7#"7D/N&"=/@<)A3FE8>E(3:HGW8QDRL=
MWM[$Y'$80AO,=I\W2-Y=K])R9[BDO=/G0D[)+9W?L0E-R36G(696<\!&N_9/
M9CMJ#Z;RAC^DI49QN=SF3F<*>3/AF$'=]VV\<[\T6 1[(/A]E ;ETXEK]CYB
MUC0-;+R=O[0VX)F$:OXGFJW/0%RQ"6L[;Z_I619F4&/"QKM['LQC6#RN]X,+
MM/&ZU5"P\8[^D0<P,8,I3S$J&$3VH9FT]O&IT5BP\7Y^*R(I60H3DR3S=-GF
MLE)7N)")Z;9F@HVW\B&/HR"243HAGR#'143C4C^XBM&/AH&-]^Z!8'L!3 ^#
M(ELLO6#UPP2Y&H_7Q _7,SES- 8<O%'_Y*R797-P9C)HD#4:U AP-D) -V%B
MHN)Y#@K0OB'99C0MI;Q!T&AM9>&/=VB5\ #TH>3!'?GVB:EB_$[^(_WN+?EZ
M=7U)AC=7G4O2_=*Y..Z?=W>)6O(4!Y9:K^*ZP-& <-P*+F500+S5LR:'@_?Y
MFTC"^IB/B>W\,?J3#%DPAWY4GABXTB*<.P3^\I#NDE^MNF63 17D,XWG:-)H
MD#@X!VX$#54>#Y^2$2_M2@8!M7S&G&B2.#@$GJ>*=!^#*4TG;.UZWB#4_SK$
MEGN.)HF# V!M0<$7D,Y%KW-\?K5)%:'?\M:,U/!QVA54$8JBMWK6@')PH+RF
MBG"EU1B^IH)<C2P79XNY@@P"A@IR-9M<'"6;5Y!!J'/Q!3.DB>3B1!JR-(+U
M?)]+EA&K3EJ^I6YL!)"-X9RI&Q.M[8 *]_'6&U@K=[ J )5;!:A<#2IW:Z R
M*%EUB.MO"U"M!OPYQ)A=S2GWO9PR"*@JP[UH4KG;(I5!R$ J5Y/*Q4GUP[P[
M=8BI_Z+0VELJM"I8YFJ6N16PS*V"9:YFF;LUEAF4G#K$M:303I<AQNZ#:YQY
M[\6902 O--2+!IJW+: 9A R%YFFB>:\@&A1:LZI"PWV\,6D]332O J)Y51#-
M6_D)9VM$,R@Y]>:;"TT3S7LOT0P"BT([P<QHI'G;0II!R%1I&FG>>Y&VOZ5*
MJP)IGD::5P'2O"J0YFFD>5M#FD%I'=*>0XS]I*J1YK\7:0:!O-)0+QII_K:0
M9A R%)JOD>:_ FEVG3@O+])<>SN%AOMX8]+Z&FE^!4CSJT":KY'F;PUI!B6[
M[B 7::Z-V5UY>.&]2#,(J$+#O6BB^=LBFD%H7:$U5AX54H]=?:+J%X&,Q&P,
M.NJBN$;$XDFFQ8[DL_SIH1&7DB?YYI31D EU 'P^YA"1Y8YZ(*EXGNSH?U!+
M P04    " #+2E-:GZ ;\+$"  #B#   #0   'AL+W-T>6QE<RYX;6S=5VUK
MVS 0_BM"/V!N8FKBD1BV0&&PC4+S85^56'8$>O%DN7/ZZZ>S;"=I=67=A['-
MH<G=/;J[1W<GF:Y;=Y+\X<BY([V2NMW0HW/-^R1I#T>N6/O.-%Q[I#)6,>=5
M6R=M8SDK6W!2,EG>W&2)8D+38JT[=:=<2PZFTVY#;VA2K"NCSY:4!H-?RA0G
MCTQNZ)9)L;=B6,N4D*=@7H+A8*2QQ'DJ?$,78&F? KP(&K <XRBAC05C$C*$
M[_VX_!DP::U7A90SP24-AF+=,.>XU7=>&18/QA<0&>7=J?$,:\M.B^4M/3L,
M/S[)WMB2VSG-@DZF8BUY!72LJ(_PZTR3 .B<45XH!:N-9@.'R6,4?-@#E_(!
M6OBMNHK=5R3TXE,);2"PU4GTA$8QA D*Q+^,%F)?A+W]K;"D$8_&?>S\;O2@
M?^^,X_>65Z(?]+Z:\V/1%WATUC3R]$&*6BL>]O[+"8LUF_S(T5CQY+/!I!R\
M@5M*'KEUXG!I^6%9L^.]FZ:IKW#.RW^0\Y^M<\TUMTQ>DO:C_S=7^2V,D_'T
M7!S1JP,Z6PE<A!OZ%>Y7>>9 ]IV03NA1.XJRY/K%.?7A'=O["_PJOE]?\HIU
MTNUF<$//\A=>BD[E\ZI[J,NXZBQ_AOMHD<VWL,\E=,E[7FY'U=;[021>\%G'
M!QR>(W?#$T<PGX#%$<"P/!@#S"=X87G^I_VLT/T$#..VBB(KU&>%^@2O&+(=
M/EB>N$_NG_A.\SQ-LPRKZ'8;9;#%ZI9E\!>/AG$##RP/9'I;K?%NXQ/R^AQ@
M/7UM0K"=XI.([12O-2#QNH%'GL>[C>4!#ZP+V.Q _G@>F*FX3YI"5S%NV G&
MD3S'$)C%^(QF&5*=##[Q_F"G)$WS/(X %F>0IA@"IQ%', ;  4/2='@//GL?
M)=-[*CG_5U/\!%!+ P04    " #+2E-:EXJ[',     3 @  "P   %]R96QS
M+RYR96QSG9*Y;L,P#$!_Q=">, ?0(8@S9?$6!/D!5J(/V!(%BD6=OZ_:I7&0
M"QEY/3P2W!YI0.TXI+:+J1C]$%)I6M6X 4BV)8]ISI%"KM0L'C6'TD!$VV-#
ML%HL/D N&6:WO606IW.D5XA<UYVE/=LO3T%O@*\Z3'%":4A+,P[PS=)_,O?S
M##5%Y4HCE5L:>-/E_G;@2=&A(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T>EOH^7%H
M5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0    ( ,M*4UJJQ"(6,P$  "("   /
M    >&PO=V]R:V)O;VLN>&ULC5'1;L(P#/R5*A^P%K0A#5%>0-N0I@V-B??0
MNM0BB2O'A8VOG]NJ&M)>]I3<V;K<7187XM.!Z)1\>1=B;FJ19IZFL:C!VWA'
M#02=5,3>BD(^IK%AL&6L <2[=)IEL]1;#&:Y&+6VG-X"$B@$*2C9$7N$2_R=
M=S Y8\0#.I3OW/1W!R;Q&-#C%<K<9":)-5U>B/%*0:S;%4S.Y68R#/; @L4?
M>M>9_+2'V#-B#Q]6C>1FEJE@A1REW^CUK7H\@RX/J!5Z0B? :ROPS-0V&(Z=
MC*9(;V+T/8SG4.*<_U,C5146L*:B]1!DZ)'!=09#K+&))@G60VY6= ;N\N@#
MFW+()FKJIBF>HPYX4P[V1D\E5!B@?%.9J+SV4VPYZ8Y>9WK_,'G4'EKG5LJ]
MAU>RY1AQ_)[E#U!+ P04    " #+2E-:)!Z;HJT   #X 0  &@   'AL+U]R
M96QS+W=O<FMB;V]K+GAM;"YR96QSM9$]#H,P#(6O$N4 -5"I0P5,75@K+A %
M\R,2$L6N"K<OA0&0.G1ALIXM?^_)3I]H%'=NH+;S)$9K!LIDR^SO *1;M(HN
MSN,P3VH7K.)9A@:\TKUJ$)(HND'8,V2>[IFBG#S^0W1UW6E\./VR./ /,+Q=
MZ*E%9"E*%1KD3,)HMC;!4N++3):BJ#(9BBJ6<%H@XLD@;6E6?;!/3K3G>1<W
M]T6NS>,)KM\,<'AT_@%02P,$%     @ RTI36F60>9(9 0  SP,  !,   !;
M0V]N=&5N=%]4>7!E<UTN>&ULK9--3L,P$(6O$F5;)2XL6*"F&V +77 !8T\:
MJ_Z39UK2VS-.VDJ@$A6%3:QXWKS/GI>LWH\1L.B=]=B4'5%\% )5!TYB'2)X
MKK0A.4G\FK8B2K636Q#WR^6#4,$3>*HH>Y3KU3.T<F^I>.EY&TWP39G 8ED\
MC<+,:DH9HS5*$M?%P>L?E.I$J+EST&!G(BY84(JKA%SY'7#J>SM 2D9#L9&)
M7J5CE>BM0#I:P'K:XLH90]L:!3JHO>.6&F,"J;$#(&?KT70Q32:>,(S/N]G\
MP68*R,I-"A$YL01_QYTCR=U59"-(9*:O>"&R]>S[04Y;@[Z1S>/]#&DWY(%B
M6.;/^'O&%_\;SO$1PNZ_/[&\UDX:?^:+X3]>?P%02P$"% ,4    " #+2E-:
M!T%-8H$   "Q    $               @ $     9&]C4')O<',O87!P+GAM
M;%!+ 0(4 Q0    ( ,M*4UH6PX<![@   "L"   1              "  :\
M  !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( ,M*4UJ97)PC$ 8  )PG
M   3              "  <P!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#
M%     @ RTI36LEX<V%2!@  6R8  !@              ("!#0@  'AL+W=O
M<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( ,M*4UJ?H!OPL0(  .(,
M   -              "  94.  !X;"]S='EL97,N>&UL4$L! A0#%     @
MRTI36I>*NQS     $P(   L              ( !<1$  %]R96QS+RYR96QS
M4$L! A0#%     @ RTI36JK$(A8S 0  (@(   \              ( !6A(
M 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( ,M*4UHD'INBK0   /@!   :
M              "  ;H3  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+
M 0(4 Q0    ( ,M*4UIED'F2&0$  ,\#   3              "  9\4  !;
H0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  .D5      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>8</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>8</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm255723d4_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://abbvie.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>abbv-20250218.xsd</File>
    <File>abbv-20250218_def.xml</File>
    <File>abbv-20250218_lab.xml</File>
    <File>abbv-20250218_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="tm255723d4_8k.htm">tm255723d4_8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="40">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "tm255723d4_8k.htm": {
   "nsprefix": "abbv",
   "nsuri": "http://abbvie.com/20250218",
   "dts": {
    "schema": {
     "local": [
      "abbv-20250218.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/exch/2023/exch-2023.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "abbv-20250218_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "abbv-20250218_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "abbv-20250218_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "tm255723d4_8k.htm"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 2,
   "axisCustom": 0,
   "memberStandard": 3,
   "memberCustom": 5,
   "hidden": {
    "total": 4,
    "http://xbrl.sec.gov/dei/2023": 4
   },
   "contextCount": 8,
   "entityCount": 1,
   "segmentCount": 8,
   "elementCount": 73,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 40
   },
   "report": {
    "R1": {
     "role": "http://abbvie.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-02-18",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm255723d4_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-02-18",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm255723d4_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "auth_ref": []
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockMember",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CountryRegion",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityListingsExchangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityListingsExchangeAxis",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings, Exchange [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityListingsTable",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Table]",
        "documentation": "Container for exchange listing information for an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_ExchangeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ExchangeDomain",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of all exchanges. MIC exchange codes are drawn from ISO 10383."
       }
      }
     },
     "auth_ref": []
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Extension",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12gTitle",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "abbv_SeniorNotes0.750Percentdue2027Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://abbvie.com/20250218",
     "localname": "SeniorNotes0.750Percentdue2027Member",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Notes 0. 750 Percentdue 2027 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "abbv_SeniorNotes1.250Percentdue2031Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://abbvie.com/20250218",
     "localname": "SeniorNotes1.250Percentdue2031Member",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Notes 1. 250 Percentdue 2031 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "abbv_SeniorNotes2.125Percentdue2028Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://abbvie.com/20250218",
     "localname": "SeniorNotes2.125Percentdue2028Member",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Notes 2. 125 Percentdue 2028 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "abbv_SeniorNotes2.125Percentdue2029Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://abbvie.com/20250218",
     "localname": "SeniorNotes2.125Percentdue2029Member",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Notes 2. 125 Percentdue 2029 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "abbv_SeniorNotes2.625Percentdue2028Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://abbvie.com/20250218",
     "localname": "SeniorNotes2.625Percentdue2028Member",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Notes 2. 625 Percentdue 2028 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "exch_XCHI": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/exch/2023",
     "localname": "XCHI",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "NYSE CHICAGO, INC. [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "exch_XNYS": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/exch/2023",
     "localname": "XNYS",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "NEW YORK STOCK EXCHANGE, INC. [Member]"
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001104659-25-015015-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-25-015015-xbrl.zip
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M^&Y@0K)#VS.5,K 4,VW3*FSW$B8#RRRY7>[F=Y3M8!&5$!-ASZ'-]FA]I8K
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M@QK>A%GZFA9*0+U=6%ILUYD!Q!ZA8W8($,2#4#W*)4C3.*#LGE9N=YC0->\
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M/1>\2E1CPG%1D*X?%E="$FVZ:2B]1DNWJG2A:E(?<\M-&$4@E$=[=5/-/C\
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MDO>JH@?W< O@#I4KA!3\Q:P85'O7*<%453ZHLYLS^I?^[VOJR']02P,$%
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M(!F336;R-DXZE3]ZM51N <Y'>T0W=(;O^' /)Q S85:*'UQ5F8Y3%']!J0M
MO\D5.?V&=H.UW\6KUF4;N1?%-LQKPM5W\1.JV!G\!_) AS%#7XSO!9@T?B"X
M]&TZT/*/]%7P]Q7*QO&#"1\OU_&):?0F'4^^W:-TO+^K?:C?N_+^OF;T>H;>
MM WEX9SU6LR48 *M<QQ)"8#N^B%M,L4Q =9LKG6#PB]^(%L@HHD$^7<FE<F2
M*VJ23U1SED38>N$N^>&^,2F:6<U1KV5H\8/JX>&G,-C2?CY"2$W69B88:<P2
M[U'Q[EG"H@*(B3"3]KHF H_"->D)QM304N/N:U1Z[^(6!Y'!4.Z[W01:EEU9
MAF.Z/4$A,9/V7/R(T4TQE*N-O)),,)'W</R8J_BBS9E)!. LU#BIU4^#_#9=
M>=Q9.JPWMZ\^(-)09T  \]"TCT!>'DR@]]J9O)NN!=,OHH[W9@HD?^_>,Q=]
MD2B-9+E(1G.9\>)+\W4(,,$JZZ!XFCQWWZ@ R;"O<87;$F*B<B@HG(ZX.ZR]
MI@T(Q.HUC5K 5F* U2&WX@=>D9F1OTV'-K\< !-Q=\8M&Z:D=0SXI'J'R=X1
MNWN(W6=[&W-0$ ^_"X,N(A-_0@9=C#]@V&OAQHU.A]^<017'LL'3:#*=&^:%
M =9R)E4J9JX8Z#C=5AT&94N_B4Q%XV!O$4S\D;';S<*Y5#97#!"N_)NR<"0F
M_K#PMK/P[A\6GH^)/RR\[2P\+7LJORT+1V#B#PMO-PMG4[F@!9C/_J8L'(F)
M/RS\0BSLZ%SR[VWS:)KI>HQ:CLD.W$#_'A3QFO)>!=K'ML(;EVL&4>V[@Q=E
M5NQ@LC QW8G*'X'19Q"*-47TE]K&+%LM/O9I\$+:]/5XQ'2CQ_5G^GP6'].=
MAC3KO?8/?QJ-;BQZ$GJ6,7!W8>5M&NH>Q&*QMWUO':9'S0[7]T@F?O VW3\(
M?=6W\?5__I7=S>R[A7R+2PU'8\DKVA&+?OXE'ED_:1M]T<8^<1^T#!NDI_ML
MP%6[B\M'F;_B@=HMPP289>U#C2H/) =P6(;&U7WBOO1:DN^SD_>X)I6T^!/;
MPZ<3V''X[E_?"-+!(2R$@'YP^:ME:"K)%J#@#0@KBURP 6D8/:HGY(,$$8M@
M'@[<-O<)3MXDU7@''J'$Q"C?6ZM/=7_SR3;M<6VT-[_M^,'M1?WF^"C6O*G>
M'(, Q&9FB+I%X#:/:[>-^DW]N!FK7AR1X[O:A^K%^V-2NSP_KS>;]<N+!<:0
M>=TQ?*96%[20;>B)V%&JEB*Y3+%0>3&XGV?)->%GV5F_1_+0&G5L8SS%<\5G
M9_B:9O!KXWP]\^KDLG%.)&.Z:Z'WE4Q.[)9()KW="+@CY5X9[^28[.EX^E#[
M0L_8]W)F^ !H7VU9.YOQ+[KZ^XP?E).GTTNN?]C^MV;[W&N*XB#J,H@[T"Z-
MXXN;6./XZK)QLP!S;ML KAS3<JANQVP#RBBXY8AD\X1<-DBVN*.^(4:;V%VV
M[5HR9&3NOA/.K)CGOY&J8N. LI5\82L$R;J0UCI 9PZ'UF!]P[3)CO>;43#=
MF643]@B%8Z9XS=0W>V_3K0,"%:>E?W9*^E\)C_!8NHOA:J!KG7T89HM:]K"\
ME!J0F]S>Q?G0WE/1^8>R796.1@ TTZ?41#9,302  W7&6J9#S1')EA,$>YK9
ML#.F>BN"\C\1T7]RQ?%2.B.W3L$TF2=Y=Y[(2%&#=;B%>[1MW (9/DTN.Z7&
MTUVV].D\%P](.!>E9<3IJE94;G9S8! FN8.M?ARK7]122UE5ZQ-2.\=#@%<
MBK+)' -(J$6L/E,PK*@2#GBV+0(R&T25^>;/9/TU)ZM-6QJ#5YK6IZHXT1('
M7P!_ S,JWN^EP7"QHAB:1OL6#-_[-A4( @!,K_5'9N)>8LV#5P9]W)C@6UOU
MRKD-Y'-_N0@>,-[INI)F,;F1#<B-NJX8)JADL==;1,!K\O!"S5 CQ,AAJ6_V
M^=?C[*VVJK;% R<8-;99WS0><3K.J-O\K#R9"VO\X(AI= "*.U*VV&H4/I=
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M]L3E6)SV59/1:!Z]_'@^'+3I4[FQNHV;"RRC^?N,'Y3GV+(MA/U-+"JZ=6:
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M/W:'>AMC S,^M1B;>TSAH_[V"O+9Z,>"':]O)^_;EG\SKV009D811UA@+G&
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M97=/+0)?M*T^HW/5X=D6;*K9[0Q;9KE9:CYDQ\0(7"J_3_"\>XMK ,X>D=>
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MX'P\]5,_)O6+6BIP=\CB!]5G+VLH(HXWCYNI3E^AS\(+=+HT$9: )^S@S%P
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M\^Z=Q$BZ9:@C_.S:/>W@_P%02P,$%     @ RTI36I-"=[C290  *\H" !0
M  !T;3(U-3<R,V0T7V5X,2TQ+FAT;>U]ZU/;V+;G=U?Y?]!D[NF"*D'S"(0\
M;FJ )-W<FTYG0OKTG)J:#[(M@SJRY"/)$/JOG_7:+VG+-L0F)GBF[NE@6]JO
MM==[_=:K7S__]OYUM_/JU[?';^"_ ?Z_5Y_//K]_^_K5S_Q?^/9G^?K5R>]O
M_A6<?_[7^[?_^6289]6+8'=G7 6?DU%<!A_BZ^!3/HJRD#\(@_.X2(9/X$%X
M].-MGWL9C*+B(LE>!/C3G9=!%7^MMJ(TN8"/^G%6Q<63US]EO7+\\M7/'Y<Q
M2)%<7%9/7K\Z>?WVZV722ZI@=WOWU<\GKY<TWKTL2@UR?'+RS[.WP=F'T^V%
MC70O4Y?/DFP0XSMWDNS)Z__8#?<.=L*='?J_X.GVX<'./^"-69(7W<Z'O((1
M!Y,XV-O9._H>DY.)R>2.GAWX)[>_\[TG=["]M].R<_L']S^Y9P?VU [-U *:
M6;?#4SM8W-3NZ?:]^N/U'Q_>O/WTYZ>SSV<??@F.?_GT]NUO;S]\?O7S'XMC
M+_?!'^OGMGV )_<N[A63J+@)=H]"O'4K?$!/7I_DPV/XJC\IDBJ!G_$ 9UE_
MD9SQ]RP.3HJ;**N"CU'Q98%OQM_]*R^^A('Z%[QE9_]PE;?\O[8_;@>_Y<5%
ME%D['[Q_?[K 0?:/]H/?HD%2YEEP?!5GDWC9N[[[[/DJ[[K:\"K*TOB&7_]3
M-!J_#$[S[05O_N[!T0$0?!X-KJ.;1T[M)U'13Z.;,CB-QDD5I<&"><NSIP?P
M#5!X=8F$OO3=WEUM*D_^GESF-EOYX_QXT=2]]VQ7>$J0#X/J,@Z.1_#+?E0N
M???W%J<E+F'WC\N@B,=%7 (U1E5R!8_*!I5 H040_Q^@*A37<#1Q42Y\^"P:
MQ8,@ 2;7OXP'DS0.SLZ"R[B(JWR5=^T]B"GX>90-@E]@X])X%&<O5GG"Q[W>
M/Y.8&%D81,&;.(VNHR(.^GDQS@LX>)"Y&WCJ/Z6#?T_REV!$G^:C<93=H ']
M4T$?;H;=SKC(QWD)(U=YD)0EW"?<A#).4_RDKIK)@.WJ0QBX0BYPY%L8>%DQ
M#MGMM/(-6$A^$<-BBC!PE_3)I71[:;0,_'6.#VKBGUC$'_B(M=MA:C6#!M<)
M\'5\56VX^FSLB^5,93PIR@EJGO#:ZC(IS15,LHO@^**(D=XJ/##XTKQ0?V._
MK=O!4<=%DO63,:PH&N43>!8N>5*!K1CW*EBLWL($S8)DF-37&>A5.DLPF^^0
M"4Z\%S-]#/1R8"8Y;0$;'Q,@OT%4P0\BXCD?\JMXU(/](Q-D=Z\^UDE4(@'+
MH\Z&]>+J.HXS>KF0+9WG']OGVT!"V9?@<S$I*_4=D/$'(GG8CN.RS/N)7(!R
MTN_'\$&!"S /^WX,BX1ITVOCN#Y5^=C=$_AY.1F/B5?@JGLWW<ZY_H!(6VW+
M!R#_W5W917N/M)VV=\AV6NO2\>^6V?D'M28+^Z->X6ZZ9PWT*_\;Z_3N/;L5
M]F8],9;]_]C:"MXE<3IX =;@1?P2?O_O29SU8WAML+4EKMA7;\[^J<;D-VU5
M^1A^LC>NU+NW>GE5Y:,7P2%^ULL+N-GZLY,TZH/. (.7>9H,8 (?W??1S.R%
MOOH9QO0,WROBZ,M6+Q[F!<QQ3'.VIW3HF1%.\[9#6AOS,^X,;\8JGJ;?\?'9
MNC:70-W#) 6RUAS<$BYX(]Y^[5]&V47<[< S(V!O?K$IW[CB!=2LBZ2L1-:6
M(!/HPH3 #?OI9("</0(VG9?CN%]-8!'T7IQ/D$V(+\+]O[Y,^I? 5X%E5P&<
M;779[5A\6CPAPJPW QCH75Z,@O.M_1#&3R,2(,!6+(Y?9PZ7<3H,VOBZF:N[
M.R'Q=L/RAT4^"BHX#!)A^%_A%++7VP%NO']'D,F H(5S&@0B,) %LEH*2]=2
MKCZ=)(,=&=';NIV-9 A'=K,)$BX>\9M@>N.HJ)1^VS9Z1=_2I.&7\7 (YP'B
M.P/!X$CF3WK#G^[O' <@-/"3 /XX8;4!WP,LWFSU<9\&WWV^OQ_:JVP5JOA$
MVP%$H''%'.<H<206S[U)!9^JW]#A?][:1<4-=@Y_E&31$!0.6/TP+@K>F*AL
MZ$G6UIRKK<&9A#(5+6.(JE#(:\H%G1)T)TTC-7KJ=EB>&8_C4Y%DMYD@B*6D
M'WS48^+4MM74/K/<<G[0$+_=CE"D-7'S?8 ?@1K4AUV^<6Y.C2LD+'F1\."N
M%J!C3$J><S_/X(-14$:IL:FL)S> 8)*,M3/K\5$T #%[%25IU$MC-:*M*M:N
M$OYD% ,[*% DE16-!70*G*K$7]=)-MA]MF_HTSD9H+;-6QV#>P -VH#G1]:O
M01E.DQ&\&$Y][#RI'AS%45:B\H$_,#^F[9$=-$-N(WGC\M@>\; ',_00/@N4
M NT?^U)6AW/ 7P&'[7:(Q>(A\]7>.?#N'%UL7'2=4')@'G03&L=O3^ZSL)IS
MH)0:3<ODNAW:&>:%>7^"RV.)!'I]'P>P>)^1#4$^AKT!HJ$'^]&8OI:!6T95
MV^'3_D4O-#/OH;\0+HBA5_P@*"_SZ\:Q@G23!WN@2P.U YW'*8Q9Y!E<5?V@
M)B(T3H9)QI:(L-;]C<O-C0.P:5J/H;H$!HYGV4.MN':;4*[G$[PJP-V2/FT'
MTC72&]R5/-L&%9]O,-^!4--QV<(>@<%[^>-T7N7Y6?OM\/QX'I)QC\K[(]AP
M%",L5&*7O$#6D 0EF2-> M;XB26@\LMB!TXGT@R.)#5^F@])Q@-_JVV>8;(M
M:R.IZ)4WM=_8"XF<8V,%#DX95RR7L=OQ2[50V3DU>4$&E'^;PZ#.H2PADA<U
M/N5N,IP+_&$N<3GIE61+5'"/6/NL\7>MC%HZI^LA<"Z!TE$M;>/I-&W#Z+0-
M98/N$GJ)'!UJ)CDLSJ3SZ^SW;A@0LP$-,1N4O"<-D2Q>,6"0<)Y_&:+#+ZX2
M/+)2;H46CN@R0\YM\2+@>$G93_.2>9Y+1N14&45?8C03)KT4R+5=O "5 6GE
M>:9D=LT512<:1 .8&S%&EO6N_#1<-/X*+R8G!,Q] %0/^ET\6&'+W7^DK][]
M_N&S_>:M831*TIL7LQ*B=K=_^I]'>_O/7R[C/Z]^QFF]?G7F>"=SUH,&P9]1
M4<!%3XP.J?VR9Z_9C%)DJOWXK!I<\Y/HJ0WI@PA/MB1^$@9Q!(:DO+%.'$CC
M*^S-YO_%,VV<\[-O.^B-:'.91_S'ZP\YZ@OY./@=_3XO20J!A$#N'/P)#&'K
MO[/\&GWD$2@C<.'.T)PN,,F$C]HOPN2F]G.05MI>?1ED8.?C6.1C D$#C"13
MQG*WXQJVFA*\[T_(T.$GF);@W<#:^G&,+RQ1W80!@*)$'0]8,]<RZCPF!L>$
M<'0\Q3Y&<:/FR>XK>%>HV.D7V!X0D1=Q[3*@K"IBF&[FR$\1E]O!V8SEX5T+
MHDF5HPK=!XF-1FN[>Z*FF(H78(IU$#H2/<'COL;C_D+'7:KC)N])T>ULW&6,
M35"GDXM$K$;0AJ8M&2ENWA4;;[#M*<MRU*/[,5 0D@.\)#;"T5)5<I*'I3I!
MG-=T8IL]-9"RZM>+]/9^%_?QWLO@=[++RA?X7KDH+X-_1ND$O[X?[[(OO\\>
M8\<S!+F%FZRV3/Z.>;?@6VOA:LDO@\\W8_C%<1'UDO[+X /HI;PM'W)<[)[C
M4U9/X3?"1M?.[Y42F;TEB\P68SNT+2SD3V]8=:8H5>58;BP^-Y)-WM2WJ/DH
M \Q8N6Q[<>BO%\N?=3O+,99HV'9K2#3X%AO28R>"_!ZG"4_B.@$KD3X  _ 2
M=/ RERFAN0W? 6^$ XC2;D?,W-(8BHX)J'AW!&9WTF<G#<@32>5@K]7%)&6=
MTQ*KBG^344<R)X0]5)M(ZJ/E36^WKGGV$_5S4%,B6TT)P>8A^8$.TRI"EPO.
MB=ZOGW+L5U(UC".73U O#DPPVCOKC0';<%4QB2TQCJ:8WL5@&*&U7 3Y**'#
MIM\U?H NUJ30EC#]:*"](/!X%F/\&#T"Z-IEQ4N9;63TJ>%+_11.%/8ZC2/4
M>6B/U29/%Y)-CPM0=5S65XZ^LOM>>C!MY>3R;EGZU1PK%WJN7YP;,7)N2RAR
MR6K7*FC>*H^_=T'W"A2^*_M>37&K&GY%]PK.N4P&,9]+/?VDU7OE(Q.Y()9J
M=2<RF9L*%.F$BD^FF)VN]JF?%,"?T>721V<&J[P<_(2O@27"L^3<#9M$=&5?
MGS;NJ[9 B*86\R/F@T]X'"L)[7K&>IK9;.V+H7.I$6C"VWT35VYH1[D-@0_:
M(1MK2J<@TO"M;W"S+;. P[ZV5?5T<Y;/DO8\:[L>-;=C_;8$BJN&2V NWTXU
M'$=SR":X#=7@E@/EV*3CH19KZ8.I,@F.Q[][BY=)T_?.NL^WN7*WVKOX:S\>
M5\;X*UP_%F?K71L_EHE/T3S@<H",CRZ*:(QZ&;T>MXXBFQO'<B+6,GA+2O:J
MRE*F^?;M&]'M3%7!>A'Z7B=CYL]NZFM14J3AS(JTU>QTU\N!FC']JQ>G^?6F
M$QRDJV.]/1A.BBP!2U>G/&A?0:;CEG!!22.RGZLNBWQRX4TWA'/!O\N4 JC*
M(:#$]<:))O4(+'P[,:)%\-+YHL"IDFI2Q>Q7/K=I]RWY'Y(TJ6Z"#<P]X!$P
M <'R6G JGLDI,W&*YR'YK5L"%9[GW'"%3%^RWE;8,[!$:ZR_9&OL+%-.IFZG
M[IRTW%MTAW6H.=$/B8?+"C)/E:7UW 51KG8/GX84C"?.\G3?G\^ !+(=',.$
M6J+_CKM*S=S6<RGYJBWE9W]C(#>(!F<!5-,19ZVOF16B8BZA-@)[<5C/2K.T
M2)0D?;! !\BVZ1<\$5F&,,S&,(M58+<#LJE;MADG5-MGG6E'R_3L>CCOMOL6
M1FP=1KR.,# 7 VN3;%L4'!ELZ&64#G%!S!5)>MMI+K7X*YM:E"Q-\I>5,S06
M*KJ,-@LF8R*FTY8-FQ:C$X._K!O\LVV111\O[,V4\WV)'@44\4.1F"TG'=M)
M ],3R4-*ZJ''+<F#S(RFX@FX#[S9(M:(I+4[<O0FGZ@8@L[-"AN$B+Q*D4G8
M( A,;.3AC0*LTDC@_05FX,#/42Z2PB%O"MG1+>^1$%P[)YK-*.K\987%VWR.
M[_U'[./>7_NXOX-6A9)C&<H1:D7&"=SMO%')/48U,OD^CK\8^,.<J353S1R/
M3PPU:<NI84PX&!(Y,"=\1$7<KEN$QB&MV=^=!)06+BT2RNNN)ED5W,X]C;:#
M97.3D4[N&%@O,?*ZAXQKO>S<24_:S4:T&=3VLNT<FLYM, +5P\=Z:MT.F:3D
M<^AOSG+U!&(_UOSDJ%]_HP.AVUFP:]?Q,-S"N]#MM+H73$:F<A9X$WS-YA*+
M:&:?[K]X>A!\W/YM.]C0Q;FG:*CBF7*EA&2D=SL*!.,>>=/#L3#C>TB1^4U1
M\/'@*BY D3IE!@$DH#2WDPE<%J!*YK$?XH2NLJW;94"Y^%]1WC'1,ADD4:',
MK')2XCT"RH(W]6,33!&2Q;J&$I,?)H,$+P1<1J!>G)5%\)+52:S\CMP[;'52
M-]DZY\8#HRAY0-@F-08Q-5QH3W:&BW! \8W113=&[H),?9CF.4V7F5\_2N'@
M*PXHT"=XX8G-4)8?+B3)RDF!-Y?,-7RMS"/JH01+RO&D(LG2!X68.,X%/IQ)
M06!$6FTHG(-D7A^N,#$)4MK[6&2H2YLT^ZIYPBC:6CM(8.K A3).H+J^S)'M
MT[JN$W)W1?25E1!/FCKL^YBK5F[I/9P:O^64Z]"B)A&+Z-U'PBK%E)25VE*G
M#"XP$^M;YN/5 8@?:RN'DCEQ*_46]_6]8NLU(ZV9MJ8O!==EE8-&+7=)/PAK
M!*%:^A]-\^QBBXH_J+Q8&2_3#A+6UCS(VIB1, .>M/Y^$%^!@!QS)E=VE:=7
M;BT=;K^1>/67L(2+6&)+S9*Z0:%UYZF0@LBXO 2U"68XL)S"*$%!EI"]5TY2
M-LKS<5PT]!:U ]W.7%MP>UINH8\5MA>7**R&2Q%6#9GU"[!4RDWAO,5ZHF[=
M0:H3JP<34J8ML4%WHPRNP$[%"'#\%?@ D3,2A0W6 *=]@8R\5(-:*95I=&V\
M0I6(- 7Y$.I*)STL$/<U6@/HV9I4EWE!>E$>8&XB4%G*%[WB-/>XT.6P0'Z#
M";HY;:E#BFO9+Y*>1"G=3..%,#:U3;1__Y[ 9I&C"04&R*D2E5HS'[IK97/#
MU-3^ IND'$@U$(9;E%JJUR<:A'ZEL'[8'F !E\E8;9*<O;53-TJY+BETT^W(
M9/L1\Q()G5T3FQY&28J!#5'#<VME).QK\[_.)^F '5)R]:,+4(TO8%/QC*^<
M4*%B>VR:=#LZQ'4[IOPXN<C%DE7>)OLXMTZ!^<=;ZQ:)V5,F%QG1$M:K6@\H
MPZ<F=#8B)D(NRTQ:,HQWMW;V-J[%Q8Z2^Y,VOX/SK?^#A#V:I!?$K-HSD=LY
M'(KMBRA+_F:J1AV(4G/FX'GDP->7$-W+U<T4/AC8;-"YY')'S;1$/:5Y\5)E
M:O)5@]4PE(F/UP3WR6I8B?#SFN ^60WH56V\)OCQ6,U\#NZGC]C!_73MX'Y0
M$NYRR1+NF-7*OQ4?K]?J*QW97W](O%<TT[]16O@+$FN!VQ5F($L\R>1^+![?
M@=IJ@#%ZG.0&4$I])VJYZIVCQ5^@G.]KVXC+@.BT11(A*)M.0A>SG/W0*$LS
M<<3P4_@[]9-1E&3B_ZM7KY6N:RKT9%G0:ZWB7MD @WW%15.&-BGI:P!\+.'Q
MA%;M#+/6<;B$W@-P(0DBK#K1^WN)Z) ]D /-V#YG=L;H>NK'Y"WW#YD4/&@8
M6/7,5B9!+\J^%)-QU2=X )!$5\#?L8BBB"88Y\>\#=2.AAB6@9.P5"O8F1'J
M7'#RDQ&#!R9 VE'!^IJ=)><X9OJPBPD\I7TN!&==!A=QADA]*>L5\I?"NQ/H
M%7'/;/3S-&6/4'K#WC&[$%[M"B>P<<H#;F -QDW%PF#?20=-3=)>#T8?)I6'
M'():7;@[6+=C1N-4!U;6@ '**A%M$5XVRK1&IRSP"BSM"7TPBFYP4@A*8+1S
MZ]!@?Q\G3_SK>_)$"_5.L423P]@FXE2"<3FA'!F$S6?&J Y>&,N-XB.2].AA
MHMU.FX T_"/R<)!(R^%;L@_"HVHP#V+/K5>LOB_*YV,)#XD_D]=<XX*1HTGN
MC>+Y$A^=Z1%U<DWKR?!U !$2#P\B^V:)]^C+LK7$7HEF EV=-_$P(D<ZDL(I
M'#MP,3NCPL*>]19J:!+B) 8B3Q^P"N8QR,,-<6X7IX?N99;7N^+8#)G!Q978
MCKQ<.0LT% A7$>@PN^W*M\H%=-5B7[8 JY;8^<^1!KJ! 1I+??KT*LE3/;"$
M/RT=HG!7&4H407*ZX4T#WO= 4BJ<<6AM6&:OG#')2(5%U&AI@KFK_4N@2(H(
MPGE.1CT*'K(CP)J2]EN@G"_+N&K$2:9$<!N@LDI)XD2[Q$A>T#:JBPAC/8,8
M;SH,@<PR#-(<0RJ&S:F0J/,1:#?P<TZ SRV'36.*S8 .U_EC?N,-;63O9MKS
MS27"X[T<SD&*4OG96?OGAMJFOUW8LUW7:1$5/.<0DU_CA=4E?5&S'(<:>^MN
MME"KD^1,PV]#STE;A8\V:3<(VM5H0HK&2_R9WT2$6VB/)C;&,3E$ZBTMH>H+
MU&/IL/(!!FHHEN@Z#Z]J>0;M>QQ:WY%2K8MUJ>!+!U-"M=\D92@:KD,HE!J:
M1IA-JGF!NUDX%W:U6=%E\MCA>P?)53*8D'[,GCWB:Y;[KF>BHZB"B.]NCMC[
M@W+9+5$JIO>D75K"\1W0+G*J3U:6G23"Y"85&2X*7-<H#;5BJ3W=?$7L8!P0
MA^,PEOQXEI&:-'V7!JG)N35V/K_*&)\IKN5WCNBLR6N?)+7%ID!ZNC+9/XR1
MXV)IT?(B<5%$*28,WK!FGO=$FX1'Q<+2JY,)EL[[3U(LHSW_<N,$(*[@SN0(
M!E=1)LBTA.]96HTQ#AV__$)NNAC7,)#HZ(QDRF<23]__8.;VDTQP]Q\UDK@@
MI9X,9^.W:$_M7&$^,U]HX. 1AP8.UJ&!!R7>1O=H]'TTD&(LSGZ7K,YZ[M-T
MRSYDUD'I[5D>I,#_TH:J9\.7:6"T',RK6ZKHHN&3^3"TE'2CG<]MTR2<ER-J
M.6*8*[1O4W-$WCV1XS*,7H;4.K%?F7R YRQMWF$TET!RBLE%<#P8)9DC^=%&
MC@I2J=_% W2@LEH=HY'41Q'/\? 8&(B[BR#P8>:;>$2M0L@.%K/$*@CP#,8C
M<1I_Q6-C+^JLO!4))=]'AMX4A1?#W:SQLJ.N189JM+J0L/@HPF =5T1GI6'K
MZOE\($U=VT12L[0:HYXDO8=,UT?JE\J6S*+B_P/[7'+1L\H[QVI[8$7(-=Y'
MV<4$Q(/EG$()&^G,WXC"2?HEP91WS)=03GEU[?ETF-Y1I(107*JR#"??&&'M
M13EO+>7!&Z#=T[J,UO'WBB^J<BIR-/77JDTO)@DZHK/8UN2845?YXZ3;?,ET
M*_RHVWFGF:2F$956IFT)L"),U4]HG V-[&YO'40]1E!O#Y%Q_]]*5?\VG/2+
MR0Q5)*]N0!MU"UR,?UFV3],G$YS'' 'NHG*5) ]-[)KW0PL?\0A9,H@B>I27
MKG!-$I+-/=JH?E1>8O7&=:FM:G@TR0>EZE81#UY:KCR2-][#,G%X=:\5K!$5
M95?*-0X7?9))J;(.IUKQUC[2CCE"5^>@2XY\+*,L/F!]944U<A'\B_'<:TZL
MD@J\<3)FUL0]YY#-<T=]ZA129XU85)ZI:\!!?+-=J"<Q3" YW7$E]M*$&T8Z
M9#;'59E[XMO=#HH6?!'F1_911P/ZFL"EN=E2UPRG"]SK2USICT3^B%3Y]GQL
M@P9KW\0B%NP<5BA!\R)<6"I!*O-)@55_3<W:T@,92Y'S#N%H8"-[("UBQ+'!
MER/6/B.58UI(OS]!H<A3(3KG5?I.(];CTV0L2"-&MJ>)UFJ1VMC&XQ13XWL0
M4QRALQ2*\ZCH1: L;/W^%=M"$MB/J%=%3':7K9^ >JU26L5"L&$EFJ:73UL?
M) 6<<5Z@=HW6Z##IJZ0<X<31..J+&XYS;$-VC\U1$RVF&@=/M%^OL4;\9F]G
M9T_)BVYG"B2+G8KM^A.)?=&X]=92GEWUMY=RL>5V]C!TP0P%EHR1,SX!^5D9
M[,NDG^\<!M8O^QCA4#[E1WI__KUL#XJ6T]B7+JN*/"V;14=>J:FU/&XL 3_Y
M$L=CS6#!O,^_J"I\U/K+Z?:"43Y4=ATJ%O#+C,I M3K1EUD*-Z:+,8B-.(@I
M]86CQB1/-0R<XWR.BMBDNG@R4> PP*1"B:8N.5;S.J$0 X-6?S$O."9$45,
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M#19]N!24F^-T/8@X-K-*1J8[00_,RLF8G@#.&%%K&PR14T<(ZZ;5T%#0R\"
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MBF?!>?\RQBY>P9GN]^GT+2 L..1(([35:2?LK$;G;6.2DC%WQZ!>;8D]P%G
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M:GY)+>%<]M<,;+6&!85X&)%7/^?H"*5HJ$X#Z@N2SD1/MSGGT-:YO0N^IIX
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MMZ[V%N!)GC@>'S[FK-OL**0&G 5*?)5XJ$ O*U5U@2_57$1R6<>B]!%/(3,
M?6 FP2$1_XVF/3?H0T*0Y^+1.R5U7!=HD,83J9M +E-5/X4BW_/CDJ/S!H5_
M2H"3F_I*\<_LG;%B*Z2>EYP@KCM-1ZD&)E*G[ DED/:")>R&/69B5:A*0I78
M)[K_**JD<9BE9'NWVKU VJ*2^;(\,H[XB!B]*K-*Z%A+PHTAIRELPR0=6SP<
MHR!2GX8.14]UC_=45UA3F=.)=?28G5A':R?6@U*1E]IIU=:-A2.[[B=CV]>
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M)<DC&Y[^Z))[J',+FAW3-^>%\"W]A4?V2K20U>4VC6:Y$EV?^.!SX9.,CVM
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MFG'O3JT9=^_8FO'>^B322W\^^?W-OU[C/W[]_-O[U_\?4$L! A0#%     @
MRTI36IAT@4[I P  N!$  !$              ( !     &%B8G8M,C R-3 R
M,3@N>'-D4$L! A0#%     @ RTI36JT"]3S "0  VW8  !4
M ( !& 0  &%B8G8M,C R-3 R,3A?9&5F+GAM;%!+ 0(4 Q0    ( ,M*4UKE
M&SNC]0P  "^?   5              "  0L.  !A8F)V+3(P,C4P,C$X7VQA
M8BYX;6Q02P$"% ,4    " #+2E-:N]#?=O8(  #/;P  %0
M@ $S&P  86)B=BTR,#(U,#(Q.%]P<F4N>&UL4$L! A0#%     @ RTI36HWC
M!#*-'P  ,,4  !$              ( !7"0  '1M,C4U-S(S9#1?.&LN:'1M
M4$L! A0#%     @ RTI36I-"=[C290  *\H" !0              ( !&$0
K '1M,C4U-S(S9#1?97@Q+3$N:'1M4$L%!@     &  8 B0$  !RJ      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>tm255723d4_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:abbv="http://abbvie.com/20250218"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:exch="http://xbrl.sec.gov/exch/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="abbv-20250218.xsd" xlink:type="simple"/>
    <context id="AsOf2025-02-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001551152</identifier>
        </entity>
        <period>
            <startDate>2025-02-18</startDate>
            <endDate>2025-02-18</endDate>
        </period>
    </context>
    <context id="From2025-02-182025-02-18_us-gaap_CommonStockMember_exch_XNYS">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001551152</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-18</startDate>
            <endDate>2025-02-18</endDate>
        </period>
    </context>
    <context id="From2025-02-182025-02-18_exch_XCHI_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001551152</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XCHI</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-18</startDate>
            <endDate>2025-02-18</endDate>
        </period>
    </context>
    <context id="From2025-02-182025-02-18_custom_SeniorNotes0.750Percentdue2027Member_exch_XNYS">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001551152</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">abbv:SeniorNotes0.750Percentdue2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-18</startDate>
            <endDate>2025-02-18</endDate>
        </period>
    </context>
    <context id="From2025-02-182025-02-18_custom_SeniorNotes2.125Percentdue2028Member_exch_XNYS">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001551152</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">abbv:SeniorNotes2.125Percentdue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-18</startDate>
            <endDate>2025-02-18</endDate>
        </period>
    </context>
    <context id="From2025-02-182025-02-18_custom_SeniorNotes2.625Percentdue2028Member_exch_XNYS">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001551152</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">abbv:SeniorNotes2.625Percentdue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-18</startDate>
            <endDate>2025-02-18</endDate>
        </period>
    </context>
    <context id="From2025-02-182025-02-18_custom_SeniorNotes2.125Percentdue2029Member_exch_XNYS">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001551152</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">abbv:SeniorNotes2.125Percentdue2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-18</startDate>
            <endDate>2025-02-18</endDate>
        </period>
    </context>
    <context id="From2025-02-182025-02-18_custom_SeniorNotes1.250Percentdue2031Member_exch_XNYS">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001551152</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">abbv:SeniorNotes1.250Percentdue2031Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-18</startDate>
            <endDate>2025-02-18</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-02-18" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-02-18" id="Fact000004">0001551152</dei:EntityCentralIndexKey>
    <dei:Security12bTitle
      contextRef="From2025-02-182025-02-18_exch_XCHI_us-gaap_CommonStockMember"
      id="xdx2ixbrl0046">Common Stock, $0.01 Par Value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2025-02-182025-02-18_exch_XCHI_us-gaap_CommonStockMember"
      id="xdx2ixbrl0047">ABBV</dei:TradingSymbol>
    <dei:DocumentType contextRef="AsOf2025-02-18" id="Fact000010">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-02-18" id="Fact000011">2025-02-18</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-02-18" id="Fact000012">ABBVIE INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-02-18" id="Fact000013">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-02-18" id="Fact000014">001-35565</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-02-18" id="Fact000015">32-0375147</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-02-18" id="Fact000016">1 North Waukegan Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-02-18" id="Fact000017">North Chicago</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-02-18" id="Fact000018">IL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-02-18" id="Fact000019">60064-6400</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-02-18" id="Fact000020">847</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-02-18" id="Fact000021">932-7900</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-02-18" id="Fact000022">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-02-18" id="Fact000023">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-02-18" id="Fact000024">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-02-18" id="Fact000025">false</dei:PreCommencementIssuerTenderOffer>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-02-18" id="Fact000026">false</dei:EntityEmergingGrowthCompany>
    <dei:Security12bTitle
      contextRef="From2025-02-182025-02-18_us-gaap_CommonStockMember_exch_XNYS"
      id="Fact000027">Common     Stock, $0.01 Par Value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2025-02-182025-02-18_us-gaap_CommonStockMember_exch_XNYS"
      id="Fact000028">ABBV</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2025-02-182025-02-18_us-gaap_CommonStockMember_exch_XNYS"
      id="Fact000029">NYSE</dei:SecurityExchangeName>
    <dei:SecurityExchangeName
      contextRef="From2025-02-182025-02-18_exch_XCHI_us-gaap_CommonStockMember"
      id="Fact000030">CHX</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="From2025-02-182025-02-18_custom_SeniorNotes0.750Percentdue2027Member_exch_XNYS"
      id="Fact000031">0.750%     Senior Notes due 2027</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2025-02-182025-02-18_custom_SeniorNotes0.750Percentdue2027Member_exch_XNYS"
      id="Fact000032">ABBV27</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2025-02-182025-02-18_custom_SeniorNotes0.750Percentdue2027Member_exch_XNYS"
      id="Fact000033">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="From2025-02-182025-02-18_custom_SeniorNotes2.125Percentdue2028Member_exch_XNYS"
      id="Fact000034">2.125%     Senior Notes Due 2028</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2025-02-182025-02-18_custom_SeniorNotes2.125Percentdue2028Member_exch_XNYS"
      id="Fact000035">ABBV28</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2025-02-182025-02-18_custom_SeniorNotes2.125Percentdue2028Member_exch_XNYS"
      id="Fact000036">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="From2025-02-182025-02-18_custom_SeniorNotes2.625Percentdue2028Member_exch_XNYS"
      id="Fact000037">2.625%     Senior Notes Due 2028</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2025-02-182025-02-18_custom_SeniorNotes2.625Percentdue2028Member_exch_XNYS"
      id="Fact000038">ABBV28B</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2025-02-182025-02-18_custom_SeniorNotes2.625Percentdue2028Member_exch_XNYS"
      id="Fact000039">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="From2025-02-182025-02-18_custom_SeniorNotes2.125Percentdue2029Member_exch_XNYS"
      id="Fact000040">2.125%     Senior Notes due 2029</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2025-02-182025-02-18_custom_SeniorNotes2.125Percentdue2029Member_exch_XNYS"
      id="Fact000041">ABBV29</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2025-02-182025-02-18_custom_SeniorNotes2.125Percentdue2029Member_exch_XNYS"
      id="Fact000042">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="From2025-02-182025-02-18_custom_SeniorNotes1.250Percentdue2031Member_exch_XNYS"
      id="Fact000043">1.250%     Senior Notes due 2031</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2025-02-182025-02-18_custom_SeniorNotes1.250Percentdue2031Member_exch_XNYS"
      id="Fact000044">ABBV31</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2025-02-182025-02-18_custom_SeniorNotes1.250Percentdue2031Member_exch_XNYS"
      id="Fact000045">NYSE</dei:SecurityExchangeName>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
